<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Oxid Med Cell Longev</journal-id><journal-id journal-id-type="iso-abbrev">Oxid Med Cell Longev</journal-id><journal-id journal-id-type="publisher-id">OMCL</journal-id><journal-title-group><journal-title>Oxidative Medicine and Cellular Longevity</journal-title></journal-title-group><issn pub-type="ppub">1942-0900</issn><issn pub-type="epub">1942-0994</issn><publisher><publisher-name>Hindawi</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">31428229</article-id><article-id pub-id-type="pmc">6681624</article-id><article-id pub-id-type="doi">10.1155/2019/7318796</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review Article</subject></subj-group></article-categories><title-group><article-title>Ankrd2 in Mechanotransduction and Oxidative Stress Response in Skeletal Muscle: New Cues for the Pathogenesis of Muscular Laminopathies</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-8062-1840</contrib-id><name><surname>Cenni</surname><given-names>Vittoria</given-names></name><email>vittoria.cenni@cnr.it</email><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref><xref ref-type="aff" rid="I2">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Kojic</surname><given-names>Snezana</given-names></name><xref ref-type="aff" rid="I3">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Capanni</surname><given-names>Cristina</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref><xref ref-type="aff" rid="I2">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Faulkner</surname><given-names>Georgine</given-names></name><xref ref-type="aff" rid="I4">
<sup>4</sup>
</xref></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-7103-8722</contrib-id><name><surname>Lattanzi</surname><given-names>Giovanna</given-names></name><email>giovanna.lattanzi@cnr.it</email><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref><xref ref-type="aff" rid="I2">
<sup>2</sup>
</xref></contrib></contrib-group><aff id="I1">
<sup>1</sup>CNR National Research Council of Italy, Institute of Molecular Genetics, Unit of Bologna, 40126 Bologna, Italy</aff><aff id="I2">
<sup>2</sup>IRCCS Istituto Ortopedico Rizzoli, 40126 Bologna, Italy</aff><aff id="I3">
<sup>3</sup>Institute of Molecular Genetics and Genetic Engineering University of Belgrade, 11010 Belgrade, Serbia</aff><aff id="I4">
<sup>4</sup>Department of Biology, University of Padua, 35121 Padua, Italy</aff><author-notes><fn fn-type="other"><p>Guest Editor: Andrey J. Serra</p></fn></author-notes><pub-date pub-type="collection"><year>2019</year></pub-date><pub-date pub-type="epub"><day>24</day><month>7</month><year>2019</year></pub-date><volume>2019</volume><elocation-id>7318796</elocation-id><history><date date-type="received"><day>4</day><month>3</month><year>2019</year></date><date date-type="rev-recd"><day>2</day><month>5</month><year>2019</year></date><date date-type="accepted"><day>19</day><month>5</month><year>2019</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2019 Vittoria Cenni et al.</copyright-statement><copyright-year>2019</copyright-year><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><p>Ankrd2 (ankyrin repeats containing domain 2) or Arpp (ankyrin repeat, PEST sequence, and proline-rich region) is a member of the muscle ankyrin repeat protein family. Ankrd2 is mostly expressed in skeletal muscle, where it plays an intriguing role in the transcriptional response to stress induced by mechanical stimulation as well as by cellular reactive oxygen species. Our studies in myoblasts from Emery-Dreifuss muscular dystrophy 2, a <italic>LMNA</italic>-linked disease affecting skeletal and cardiac muscles, demonstrated that Ankrd2 is a lamin A-binding protein and that mutated lamins found in Emery-Dreifuss muscular dystrophy change the dynamics of Ankrd2 nuclear import, thus affecting oxidative stress response. In this review, besides describing the latest advances related to Ankrd2 studies, including novel discoveries on Ankrd2 isoform-specific functions, we report the main findings on the relationship of Ankrd2 with A-type lamins and discuss known and potential mechanisms involving defective Ankrd2-lamin A interplay in the pathogenesis of muscular laminopathies.</p></abstract><funding-group><award-group><funding-source>Ministarstvo Prosvete, Nauke i Tehnolo&#x00161;kog Razvoja</funding-source><award-id>173008</award-id></award-group><award-group><funding-source>Ministero dell'Istruzione, dell'Universit&#x000e0; e della Ricerca</funding-source><award-id>2015FBNB5Y</award-id></award-group><award-group><funding-source>Associazione Alessandra Proietti Onlus</funding-source></award-group><award-group><funding-source>Associazione Italiana Distrofia Muscolare di Emery-Dreifuss</funding-source></award-group></funding-group></article-meta></front><body><sec id="sec1"><title>1. Introduction</title><p>Ankrd2 (ankyrin repeats containing domain 2) or Arpp (ankyrin repeat, PEST sequence, and proline-rich region) is a member of the MARP (muscle ankyrin repeat protein) family of proteins that also includes Ankrd1, or Carp (Cardiac Ankyrin Repeat Protein), and Ankrd23, or DARP (Diabetes-related Ankyrin Repeat Protein) [<xref rid="B1" ref-type="bibr">1</xref>]. As we will describe in detail in this review, Ankrd2 is principally expressed in skeletal muscle, where it plays an intriguing role in the transcriptional response to stress induced by mechanical stimulation, as well as by cellular ROS (reactive oxygen species). In particular, although the Ankrd2 knockout mouse model has revealed that Ankrd2 is not necessary for life nor the direct cause of any muscular disorder, multiple evidence obtained from muscular cell lines or primary cultures from patients affected by muscular diseases suggest that an anomalous expression level of Ankrd2, as well as defective nuclear recruitment of the protein, might contribute to a muscular phenotype. Very recently, we found that Ankrd2 is a novel interactor of A-type lamins, which are produced by the <italic>LMNA</italic> gene and are the major constituents of the nuclear lamina. Mutations of <italic>LMNA</italic> gene are the cause of a substantial number of pathologies, some of which affecting skeletal and cardiac muscles. Moreover, altered expression of Ankrd2 was detected in myopathies [<xref rid="B2" ref-type="bibr">2</xref>], cardiomyopathies [<xref rid="B3" ref-type="bibr">3</xref>], and some tumors [<xref rid="B4" ref-type="bibr">4</xref>]. In this review, apart from describing the latest advances related to Ankrd2, including an ever-growing interest for Ankrd2 isoform-specific functions, we will report the main findings on Ankrd2 and its relation to lamins and discuss known and potential mechanisms, through which defective Ankrd2-lamin A interplay might have a role in the pathogenesis of <italic>LMNA</italic>-related muscular disorders.</p></sec><sec id="sec2"><title>2. Ankrd2 in Striated Muscles</title><p>Ankrd2, together with other proteins of the MARP family, is considered as STRaND (shuttling transcriptional regulators and non-DNA-binding protein), having signature features: shuttling from the cytoplasm to the nucleus, absence of DNA binding, and regulation of transcription via interaction with transcription factors [<xref rid="B5" ref-type="bibr">5</xref>]. Recently, data from Wette et al., obtained on single muscle fibers, have shown that Ankrd2 is mostly found (&#x0003e;70% of total Ankrd2) in the cytosol [<xref rid="B6" ref-type="bibr">6</xref>]. The remaining amount is distributed between intracellular structures, including the sarcomere and the nucleus, with proportions that reflect the physiology, such as the type (slow/fast) or the condition (forming/mature/regenerating/injured), of the fiber considered. In healthy striated muscle, Ankrd2 is found at the sarcomeric I-band [<xref rid="B7" ref-type="bibr">7</xref>, <xref rid="B8" ref-type="bibr">8</xref>] where it contributes to the formation and function of the I-band mechanosensory complex, probably via interaction with calpain 3 and the elastic portion of titin (N2A region) [<xref rid="B7" ref-type="bibr">7</xref>, <xref rid="B9" ref-type="bibr">9</xref>]. As extensively described in the next sections, Ankrd2 also interacts with nuclear proteins with both structural and enzymatic roles [<xref rid="B1" ref-type="bibr">1</xref>] and is accumulated in nuclei of injured muscle [<xref rid="B10" ref-type="bibr">10</xref>]. An overview of the main structural and functional features of Ankrd2, including protein domains, posttranslational modifications, expression profile, proposed functions, interacting proteins, and pathways affected by <italic>ANKRD2</italic> silencing in human myoblasts, is given in <xref rid="tab1" ref-type="table">Table 1</xref>. In the nucleus, Ankrd2 participates in the regulation of genes involved in the cell cycle, myogenesis, and inflammatory response [<xref rid="B11" ref-type="bibr">11</xref>&#x02013;<xref rid="B15" ref-type="bibr">15</xref>]. Of note, in mature muscle cells, the evidence reporting that the majority of Ankrd2 is freely diffusible in the cytosol [<xref rid="B6" ref-type="bibr">6</xref>] has for the first time pointed to the open question if Ankrd2, besides being involved in sarcomeric activity, might also participate in cellular functions in other subcellular districts, thus suggesting a role as a downstream signal transducer in mechanosignaling pathways. It is important to note that despite accumulated findings from cell culture experiments, direct evidence of Ankrd2 function in mature healthy and diseased striated muscles is still missing.</p><sec id="sec2.1"><title>2.1. Ankrd2 Expression in Skeletal Muscle</title><p>Ankrd2 was reported for the first time in a study performed in 2000 by Kemp and colleagues as a protein upregulated in murine muscle exposed to prolonged passive stretch (7 days) [<xref rid="B16" ref-type="bibr">16</xref>]. Preferential expression in skeletal muscle, more specifically in slow (type I) muscle fibers, and responsiveness to mechanical stress are signature features of this protein. Recently, Ankrd2 was confirmed to be the most abundant MARP protein in human skeletal muscle, being ~30-fold more expressed than DARP and ~150-fold more than Ankrd1 [<xref rid="B6" ref-type="bibr">6</xref>]. In this study, performed on a group of four subjects, the absolute amount of Ankrd2 was subject-specific, ranging from 1.6 to 4.3 <italic>&#x003bc;</italic>mol/kg net weight, and proportional to the content of myosin heavy chain I (MHCI) protein, which is a marker of slow (type I) muscle fibers [<xref rid="B6" ref-type="bibr">6</xref>]. Almost double the amount of Ankrd2 was measured in slow (type I) fibers compared to that of fast (type II) fibers microdissected from the <italic>vastus lateralis</italic> (presenting approximately 32% of slow muscle fibers [<xref rid="B17" ref-type="bibr">17</xref>]), corroborating Ankrd2 preferential expression in slow fibers [<xref rid="B6" ref-type="bibr">6</xref>].</p><p>Although the existence of Ankrd2 isoforms was reported in 2003 by Miller et al. [<xref rid="B7" ref-type="bibr">7</xref>], their specific expression and localization in human skeletal and cardiac muscles, as well as in primary human myoblasts and myotubes, have been recently determined by studies in which their discrimination was enabled by specific antibodies [<xref rid="B6" ref-type="bibr">6</xref>, <xref rid="B18" ref-type="bibr">18</xref>].</p><p>The most important Ankrd2 isoforms, namely, S-Ankrd2 (333 aa) and M-Ankrd2 (360 aa), are identical, except for 27 aa extension at the N-terminus of M-Ankrd2. According to qPCR results, the expression of Ankrd2 isoforms is regulated at the transcriptional level [<xref rid="B18" ref-type="bibr">18</xref>]. S-Ankrd2 is expressed in both heart and skeletal muscles [<xref rid="B18" ref-type="bibr">18</xref>] where it is the predominant form [<xref rid="B6" ref-type="bibr">6</xref>, <xref rid="B18" ref-type="bibr">18</xref>]. The well-known chessboard pattern of Ankrd2 expression observed in transversal sections of skeletal muscle may be attributed almost exclusively to S-Ankrd2 [<xref rid="B6" ref-type="bibr">6</xref>, <xref rid="B18" ref-type="bibr">18</xref>], which has been therefore proposed as the canonical Ankrd2 isoform. Although still a matter of debate, in mature muscle fibers, the small amount of M-Ankrd2 has been identified in nuclei [<xref rid="B18" ref-type="bibr">18</xref>]. In human myoblasts, S-Ankrd2 is expressed mainly in nuclei at a low level, while in myotubes, it is upregulated and localized in the cytoplasm. M-Ankrd2 is also upregulated upon differentiation of myoblasts to myotubes; however, it maintains its nuclear localization. Striking differences in expression and localization of Ankrd2 isoforms may mirror their different functions which however need to be further explored [<xref rid="B18" ref-type="bibr">18</xref>]. For example, M-Ankrd2 might have a more regulatory role, being predominantly nuclear, while sarcomeric and cytosolic S-Ankrd2 may have a structural and downstream signaling role, respectively. Domain organization, alignment, and updated database entries for all five Ankrd2 isoforms are shown in Figures <xref ref-type="fig" rid="fig1">1(a)</xref>&#x02013;<xref ref-type="fig" rid="fig1">1(c)</xref>, respectively.</p></sec><sec id="sec2.2"><title>2.2. Ankrd2 Expression in Cardiac Muscle</title><p>Ankrd2 is expressed in the human heart, including ventricles, the interventricular septum, and the apex of the heart [<xref rid="B4" ref-type="bibr">4</xref>, <xref rid="B19" ref-type="bibr">19</xref>], at a lower level compared to skeletal muscle. Ankrd2 expression in the heart is potentially regulated by cardiac-specific transcription factors Nkx2.5, Hand2, and Ankrd1 as demonstrated by their interaction with the <italic>ANKRD2</italic> promoter or by dual luciferase assay [<xref rid="B20" ref-type="bibr">20</xref>, <xref rid="B21" ref-type="bibr">21</xref>]. Transcriptome profiling confirmed a lower level of Ankrd2 in the ventricles of human adult heart, compared to Ankrd1 [<xref rid="B22" ref-type="bibr">22</xref>]. Both S- and M-Ankrd2 isoforms are expressed in cardiac muscle; they have sarcomeric localization and are almost absent from nuclei [<xref rid="B18" ref-type="bibr">18</xref>]. The latter finding and the known interaction between Ankrd2 and the gap junction protein ZO-1 [<xref rid="B20" ref-type="bibr">20</xref>], enriched in ICDs, suggest a role for Ankrd2 in intercellular communication, which merits further investigation. In neonatal rat cardiomyocytes (NRCM), both sarcomeric and nuclear localizations of Ankrd2 were investigated during cellular differentiation and not shown to be affected by the maturation stage [<xref rid="B22" ref-type="bibr">22</xref>]. Moreover, doxorubicin had no effect on Ankrd2 expression, as opposed to Ankrd1, suggesting that Ankrd2 is not involved in cellular response to this cardiotoxic antineoplastic drug.</p><p>It is interesting that, in addition to mild phenotype in skeletal muscle, morphology, basal cardiac function, and cardiac development were not impaired in triple knockout mice for three members of the MARP family (Ankrd1, Ankrd2, and DARP) up to 17 months of age [<xref rid="B23" ref-type="bibr">23</xref>]. Hypertrophic response to acute pressure overload induced by transverse aortic constriction was also unaffected. It is possible that Ankrd2 is involved in the response to other types of cardiac stress, still to be determined. On the other hand, as demonstrated for Ankrd1, overexpression of Ankrd2 may have more striking consequences. Overexpressed mouse Ankrd1 is indeed involved in inhibition of cardiac hypertrophy and development of fibrosis in response to pressure overload- and isoproterenol-induced cardiac hypertrophy [<xref rid="B24" ref-type="bibr">24</xref>].</p><p>Apart from altered expression in skeletal muscle disorders, Ankrd2 was found upregulated in dilated cardiomyopathy patients [<xref rid="B3" ref-type="bibr">3</xref>]. Together with several titin ligands associated with sarcomeric mechanosensory complexes, the expression pattern of Ankrd2 was determined in endomyocardial biopsies of patients with advanced idiopathic dilated cardiomyopathy (IDCM) characterized by extensive remodeling of the left ventricle [<xref rid="B25" ref-type="bibr">25</xref>]. Expression of Ankrd2, as well as Ankrd1 and TRIM63, was induced and in correlation with the disease stage. Ankrd2 expression was significantly higher in patients with severe symptoms, compared to patients with moderate symptoms. Although this finding has no clinical significance, experimental evidence strongly supports the involvement of Ankrd2 in pathological cardiac remodeling [<xref rid="B25" ref-type="bibr">25</xref>].</p></sec><sec id="sec2.3"><title>2.3. Ankrd2 and Mechanotransduction in Skeletal Muscle</title><p>Mechanotransduction is the ability of cells to sense external mechanical forces, create biochemical intracellular signals, and trigger the expression of specific genes that drive the adaptation to mechanical changes. An incorrect mechanotransduction may affect muscle differentiation, myofiber turnover, and stem cell renewal [<xref rid="B26" ref-type="bibr">26</xref>].</p><p>Ankrd2 plays an important role in sensing mechanical changes in skeletal myofibers. It is found at the elastic I-band segment of the sarcomere, where a well-defined signalosome, composed by several structural and regulatory proteins, resides [<xref rid="B10" ref-type="bibr">10</xref>]. In vitro studies suggest that Ankrd2 might be assembled on the N2A spring element of the giant protein titin [<xref rid="B7" ref-type="bibr">7</xref>]. Titin is the largest of mammalian proteins, spanning over half of a sarcomere, with its N-terminus located in the Z-disc and its C-terminus located in the M-line. In striated muscle, one of titin's classical roles is to provide elasticity to sarcomeres [<xref rid="B27" ref-type="bibr">27</xref>]. Titin is characterized by multiple domains that interact with several sarcomeric proteins and also with enzymes regulating its own properties and resulting in the modulation of its stiffness. In humans, mutations or partial deletion of titin might cause muscular dystrophies, such as Tibial Muscular Dystrophy (TMD) [<xref rid="B28" ref-type="bibr">28</xref>] or limb-girdle muscular dystrophy 2J (LGMD-2J) [<xref rid="B29" ref-type="bibr">29</xref>]. In vitro evidence demonstrates that besides titin [<xref rid="B7" ref-type="bibr">7</xref>], Ankrd2 might also interact with calpain 3 [<xref rid="B9" ref-type="bibr">9</xref>] and Z-disc proteins telethonin/TCAP [<xref rid="B1" ref-type="bibr">1</xref>] and ZASP6 [<xref rid="B30" ref-type="bibr">30</xref>]. The interaction network of Ankrd2 is presented in <xref ref-type="fig" rid="fig2">Figure 2</xref>. In particular, calpain 3, a Ca<sup>2+</sup>-dependent protease, coordinates signal transduction from other sarcomeric regions, including Z-disc and M-line where other signaling complexes are found. Interestingly, in the HEK293 cell line, calpain 3 binds and cuts murine Ankrd2 at the Arg104 of its PEST sequence [<xref rid="B31" ref-type="bibr">31</xref>] suggesting that calpain 3-mediated proteolysis of Ankrd2 might have a role in Ankrd2 sarcomeric sequestration. However, since these findings have been obtained on recombinant proteins or by using nonmuscular cellular models [<xref rid="B9" ref-type="bibr">9</xref>, <xref rid="B31" ref-type="bibr">31</xref>] and since in skeletal muscle, the access of calpain 3 to substrates is restricted, being the majority of the enzyme sequestered by titin [<xref rid="B32" ref-type="bibr">32</xref>], results on Ankrd2 proteolysis by calpain 3 in muscular cells still need a proper validation.</p><p>Insufficient Ankrd2 recruitment at the I-band has been observed in exercised mice affected by a progressive muscular dystrophy due to an inactivation of calpain 3 (CAPN3-KI mice) [<xref rid="B33" ref-type="bibr">33</xref>]. Although this study does not provide sufficient proofs of Ankrd2 proteolysis by calpain 3, for example, loss of Ankrd2 or cleavage to a lower band, the altered Ankrd2 localization in CAPN3-KI muscle suggests that calpain 3 protease activity might be involved (directly or indirectly) in Ankrd2 recruitment at the sarcomere. The importance of a functional signalosome composed of Ankrd2 (as well as other MARPs), calpain 3, and the N2A region of titin is also observed in mdm (muscular dystrophy with myositis) mice, a model for human TMD, caused by the deletion of a large portion of the N2A region, bound by calpain 3. Homozygous mdm mice show a severe and progressive muscular degeneration. Interestingly, Ankrd2 and other MARPs are more abundantly expressed in the skeletal muscles of mdm when compared to wild-type mice [<xref rid="B34" ref-type="bibr">34</xref>]. In vitro, Ankrd2 also interacts with Z-disc proteins, including telethonin/TCAP [<xref rid="B1" ref-type="bibr">1</xref>] and ZASP6 [<xref rid="B30" ref-type="bibr">30</xref>]. Z-disc is involved in conveying mechanical signals and acts as a signaling hub for communication with the nucleus. On the other hand, telethonin links titin to the Z-disc [<xref rid="B35" ref-type="bibr">35</xref>]. Mutation of telethonin encoding gene (<italic>TCAP</italic>) may cause intense biomechanical stress, maladaptation, apoptosis, and global heart failure, as well as LGMD-2G [<xref rid="B36" ref-type="bibr">36</xref>]. ZASP has several isoforms containing PDZ and LIM domains [<xref rid="B30" ref-type="bibr">30</xref>]. Interestingly, in vitro studies have demonstrated that point mutations in the <italic>ZASP6</italic> gene causative for a muscular disease called ZASPopathy prevented ZASP6 interaction with Ankrd2, opening the question of Ankrd2 involvement in the pathophysiology of this myofibrilar myopathy [<xref rid="B30" ref-type="bibr">30</xref>]. Myopalladin is a Z-disc protein involved in sarcomere assembly and regulation of gene expression and similarly to Ankrd2 is involved in bringing sarcomeric signals to the nucleus of muscle cells [<xref rid="B37" ref-type="bibr">37</xref>]. It is intriguing that, despite interacting with both Ankrd1 and Ankrd23 [<xref rid="B7" ref-type="bibr">7</xref>], myopalladin was not shown to bind Ankrd2, neither in vivo nor in vitro. Sarcomeric signalosomes have to be considered as highly dynamic complexes. Their protein components are subjected to a multitude of posttranslational modifications (PTMs) which might affect peculiar properties including their availability and stability, accessibility to interactors, turnover, and intracellular localization. This is the case, for example, of the binding between members of Z-disc FATZ (calsarcin/myozenin), myotilin, and Enigma families, which are modulated by phosphorylation [<xref rid="B38" ref-type="bibr">38</xref>]. As a matter of fact, in addition to structural proteins, sarcomeric signalosomes also contain protein-modifying enzymes, including protein kinases (PKC alpha, CaMKII <italic>&#x003b4;</italic>, Erk1/2, and PKA [<xref rid="B39" ref-type="bibr">39</xref>]), E3 ubiquitin ligases (Mdm2 [<xref rid="B40" ref-type="bibr">40</xref>], TRIM63/MURF1 [<xref rid="B41" ref-type="bibr">41</xref>]), and autophagic protein carriers (p62/SQSTM1 [<xref rid="B42" ref-type="bibr">42</xref>]). Therefore, genetic mutations of both structural and enzymatic proteins of the sarcomere, causing a gain or a loss of function, may result in an impaired sensing of the mechanical stress and might be responsible for an inadequate transcriptional response, with harmful consequences for cell physiology.</p><p>Accordingly, also defects in Ankrd2 PTMs, including phosphorylation or proteolysis, by altering Ankrd2 binding to specific interactors or intracellular localization, might elicit pathogenetic effects.</p><p>Combining the aforementioned information together, we can hypothesize a scenario in which in muscle cells, Ankrd2 might cover multiple roles: a sensor one at the I-band of the sarcomere, where an Ankrd2 fraction might sense the stress, and a transducer one distributed between the cytoplasm, where the more abundant pool of Ankrd2 resides [<xref rid="B7" ref-type="bibr">7</xref>], and the nucleus of muscle cells [<xref rid="B37" ref-type="bibr">37</xref>] where a fraction of Ankrd2 is detected following stress condition. By mechanisms involving phosphorylation or other PTMs, Ankrd2 might dynamically translocate from the sarcomere, to the cytoplasm and to the nucleus and <italic>vice versa</italic>, participating in the integration of signals derived from mechanosensors or activated by oxidative stress, resulting in the modulation of transcriptional response to stress.</p><p>However, since the majority of the interactions between Ankrd2 and sarcomeric and nonsarcomeric proteins have been identified using recombinant proteins and in nonmuscular cellular systems, until their validation on skeletal muscle, the functional relevance of Ankrd2 association with these proteins remains to be demonstrated, and the role and the involvement of Ankrd2 in the physiology of muscle cells might at the moment be only speculated.</p></sec></sec><sec id="sec3"><title>3. Ankrd2 in the Interplay between Oxidative and Mechanical Stresses</title><p>Physical exercise, including moderate and intense muscular activity, results in an increase of ROS. During or after aerobic exercise, as well as anaerobic exercise, the general increase of substrate utilization combined with the increase of oxygen uptake results in the activation of specific metabolic pathways, triggering the generation of ROS [<xref rid="B43" ref-type="bibr">43</xref>]. Although the exact redox mechanisms underlying the formation of exercise-induced ROS remain elusive to date, mitochondria, glutathione peroxidase, superoxide dismutase, catalase, NADPH oxidases, and xanthine oxidases have all been identified as potential contributors to ROS production. ROS themselves play a controversial role, since at high concentration they are detrimental for muscle biology [<xref rid="B44" ref-type="bibr">44</xref>]. However, low doses of ROS are fundamental to drive exercise adaptations, triggering molecular pathways that culminate with angiogenesis, mitochondria biogenesis, and muscle hypertrophy [<xref rid="B43" ref-type="bibr">43</xref>]. We hypothesize that upregulation of Ankrd2 in muscle exposed to mechanical stress is at least partly regulated by altered levels of ROS, as a consequence of increased muscle damage and regeneration [<xref rid="B45" ref-type="bibr">45</xref>].</p><sec id="sec3.1"><title>3.1. Ankrd2 Upregulation in Response to Mechanical and Oxidative Stresses</title><sec id="sec3.1.1"><title>3.1.1. Mechanical Stress</title><p>Although considered as a multitasking protein, the most striking signature of Ankrd2 is its stress-responsive function. Ankrd2 involvement in the physiology of stressed healthy and diseased muscles has been extensively studied. Ankrd2 expression increases in stress conditions caused by the application of mechanical forces. This was reported for the first time in murine <italic>tibialis anterior</italic> muscles exposed to passive stretch [<xref rid="B16" ref-type="bibr">16</xref>]. Subsequent studies further suggested that the increase of Ankrd2 upon passive stretch could be involved in the phenotypic adaptation of fast to slow fibers, which is generally related to long-endurance activities [<xref rid="B46" ref-type="bibr">46</xref>]. Increase of Ankrd2 expression in both murine and human muscles has also been reported following jumping exercise [<xref rid="B47" ref-type="bibr">47</xref>, <xref rid="B48" ref-type="bibr">48</xref>] and eccentric contraction [<xref rid="B49" ref-type="bibr">49</xref>, <xref rid="B50" ref-type="bibr">50</xref>] as well as denervation which reproduces muscle morphogenesis [<xref rid="B8" ref-type="bibr">8</xref>]. Of note, Ankrd2 expression in murine muscle is not stimulated by isometric contraction [<xref rid="B50" ref-type="bibr">50</xref>], while it is downregulated in inactive muscles [<xref rid="B51" ref-type="bibr">51</xref>, <xref rid="B52" ref-type="bibr">52</xref>]. Increased expression of Ankrd2 in skeletal muscle in response to mechanical stress seems to be evolutionarily conserved. Recently, we have demonstrated mild upregulation of zebrafish Ankrd2 in skeletal muscle subjected to endurance exercise training by forced swimming [<xref rid="B53" ref-type="bibr">53</xref>].</p><p>Ankrd2 increase upon stress stimuli probably strengthens its structural and regulatory functions within the sarcomere. Accordingly, upregulation of Ankrd2 by ROS might contribute to initial events in the adaptative remodeling of exposed fibers, possibly by promoting sarcomerogenesis, the switch from fast to slow fibers [<xref rid="B46" ref-type="bibr">46</xref>], and the increase of the mechanotransducing activity.</p></sec><sec id="sec3.1.2"><title>3.1.2. Oxidative Stress</title><p>During oxidative stress caused by exposure of myoblasts to H<sub>2</sub>O<sub>2</sub>, Ankrd2 expression is slightly upregulated [<xref rid="B15" ref-type="bibr">15</xref>]. From a molecular point of view, Ankrd2 gene activation by ROS might be regulated by the well-known ROS-dependent activation of the transcription factor NF-<italic>&#x003ba;</italic>B [<xref rid="B54" ref-type="bibr">54</xref>]. As a matter of fact, although direct demonstration is missing, it is possible that upon oxidative stress, ROS-dependent increase of Ankrd2 expression occurs through two putative NF-<italic>&#x003ba;</italic>B-binding sites within the Ankrd2 gene promoter [<xref rid="B12" ref-type="bibr">12</xref>, <xref rid="B55" ref-type="bibr">55</xref>]. However, the contribution of muscle-specific transcription factors and the possibility that ROS controls the Ankrd2 level by affecting its protein stability cannot be ruled out. Ankrd2 upregulation in some human dilated cardiomyopathies [<xref rid="B3" ref-type="bibr">3</xref>] and congenital myopathies [<xref rid="B2" ref-type="bibr">2</xref>] might be also related to an altered response to mechanical strain, as well as to altered levels of ROS reported in these disorders, as a consequence of increased muscle damage and regeneration [<xref rid="B45" ref-type="bibr">45</xref>].</p></sec></sec><sec id="sec3.2"><title>3.2. Nuclear Translocation of Ankrd2 under Stress Conditions</title><p>Apart from increasing the Ankrd2 expression level, oxidative stress also induces Ankrd2 to partly relocate to the nucleus of muscle cells. For example, in differentiated C2C12 muscle cells, Ankrd2 is shuttled in the nucleus upon cellular exposure to ROS [<xref rid="B15" ref-type="bibr">15</xref>], following phosphorylation of Ankrd2 at Serine 99 [<xref rid="B15" ref-type="bibr">15</xref>].</p><p>In mature muscle injured by cardiotoxin injection, Ankrd2 translocates to the nuclei of myofibers located adjacent to severely damaged myofibers [<xref rid="B10" ref-type="bibr">10</xref>]. Similarly, Ankrd2 was shown to translocate to the nucleus also in healthy and CAPN3-KI muscles from mice subjected to exercise [<xref rid="B33" ref-type="bibr">33</xref>]. Opposite to findings reported for C2C12 muscle cells exposed to ROS, mechanisms ruling Ankrd2 nuclear localization in mature muscle cells remain hitherto to be determined. Further studies are needed to assess if Ankrd2 localization occurs in a fashion similar to that reported for ROS-treated C2C12 [<xref rid="B15" ref-type="bibr">15</xref>], involving Ankrd2 PTMs, or by the expression and/or activation of a specific nuclear Ankrd2 form, still to be determined.</p><p>Importantly, both nuclear translocation and increased expression of Ankrd2 induced by ROS or myogenic differentiation are related to retardation of myogenic differentiation, allowing cells to properly overcome stress before completing the differentiation program [<xref rid="B11" ref-type="bibr">11</xref>, <xref rid="B15" ref-type="bibr">15</xref>]. In human myoblasts, this function is executed via its interaction with DNA-binding proteins, including transcription factors, such as the Y-box transcription factor 1 (YB1), the promyelocytic leukemia protein (PML), and p53 [<xref rid="B1" ref-type="bibr">1</xref>], whereas in primary myoblasts from mdm mice, Ankrd2 was shown to physically interact with the inhibitor of DNA-binding protein 3, ID3 [<xref rid="B13" ref-type="bibr">13</xref>]. Moreover, upon muscle stress stimulation, Ankrd2 was also shown to colocalize with acetylated histones, which generally mark active chromatin, in the nucleus of myocytes [<xref rid="B10" ref-type="bibr">10</xref>].</p><p>Nuclear Ankrd2 overexpression induced by ROS has a different outcome in regard to the phase of the cell cycle [<xref rid="B11" ref-type="bibr">11</xref>]. In cycling myoblasts, Ankrd2 overexpression induces apoptosis, and this effect is probably mediated by Ankrd2 and p53-dependent upregulation of p21 [<xref rid="B1" ref-type="bibr">1</xref>, <xref rid="B11" ref-type="bibr">11</xref>]. On the other hand, Ankrd2 overexpression impairs myogenic differentiation through downregulation of MyoD and myogenin as well as their target Myh1, a terminal differentiation marker [<xref rid="B11" ref-type="bibr">11</xref>]. Supporting the altered myogenic program, Ankrd2 overexpressing myotubes also express Myf-5, which is normally expressed in cycling myoblasts [<xref rid="B11" ref-type="bibr">11</xref>]. An intriguing, albeit unexplored evidence of the transcriptional role of Ankrd2 came from the studies of triple knockout mice lacking all three MARPs [<xref rid="B56" ref-type="bibr">56</xref>]. They expressed a longer titin isoform, hinting at an unexpected link between titin gene expression and MARPs [<xref rid="B56" ref-type="bibr">56</xref>].</p><p>Studies from our laboratories have demonstrated that Ankrd2 also modulates the activity of NF-<italic>&#x003ba;</italic>B, through direct interaction with the NF-<italic>&#x003ba;</italic>B repressor p50 [<xref rid="B12" ref-type="bibr">12</xref>]. NF-<italic>&#x003ba;</italic>B is a transcription factor composed of homo- and heterodimers, affecting the expression of genes related to inflammatory and cell survival responses [<xref rid="B57" ref-type="bibr">57</xref>]. The interaction between Ankrd2 and p50 abrogates NF-<italic>&#x003ba;</italic>B activation, resulting in a negative regulation of its downstream genes. Moreover, p50/p50 homodimer negatively regulates the expression of Ankrd2 by binding its promoter, in a classic feedback inhibition manner [<xref rid="B12" ref-type="bibr">12</xref>]. In this condition, we have shown a significant reduction of proinflammatory cytokines, including IL-1<italic>&#x003b2;</italic> and IL-6 [<xref rid="B12" ref-type="bibr">12</xref>] that, at high concentrations, may cause proteolysis in muscle and participate in muscle wasting [<xref rid="B45" ref-type="bibr">45</xref>, <xref rid="B58" ref-type="bibr">58</xref>].</p></sec></sec><sec id="sec4"><title>4. Lamin A/C and Muscular Laminopathies</title><sec id="sec4.1"><title>4.1. Role of Lamin A/C in Muscular Cellular Physiology</title><p>A-type lamins, including lamin A and lamin C, are the main products of the <italic>LMNA</italic> gene and are the major constituents of the nuclear lamina, a filamentous meshwork underneath the nuclear envelope that can be found in all vertebrate cells [<xref rid="B59" ref-type="bibr">59</xref>]. Lamin A is transcribed and translated as a precursor protein, prelamin A, which undergoes complex posttranslational processing [<xref rid="B59" ref-type="bibr">59</xref>]. Final cleavage by the protease ZMPSTE24 (zinc metallopeptidase STE24) eliminates the last 15 amino acids of prelamin A, releasing a short peptide and mature lamin A [<xref rid="B60" ref-type="bibr">60</xref>]. Notably, prelamin A and its processing pathway have been implicated in both physiological and pathogenic mechanisms [<xref rid="B59" ref-type="bibr">59</xref>].</p><p>Prelamin A increase occurs during the first steps of myoblast differentiation [<xref rid="B61" ref-type="bibr">61</xref>], and prelamin A-mediated recruitment of the nuclear envelope proteins SUN1, SUN2 [<xref rid="B62" ref-type="bibr">62</xref>], and Samp1 [<xref rid="B63" ref-type="bibr">63</xref>] is required for proper myonuclear positioning during myogenic differentiation. In cultured fibroblasts, prelamin A modulation during stress response is a physiological mechanism related to import of DNA repair factors [<xref rid="B64" ref-type="bibr">64</xref>] or activation of chromatin remodeling enzymes [<xref rid="B65" ref-type="bibr">65</xref>]. However, anomalous prelamin A accumulation, due to specific mutations in the <italic>LMNA</italic> or <italic>ZMPSTE24</italic> genes [<xref rid="B59" ref-type="bibr">59</xref>], causes toxicity leading to cellular senescence [<xref rid="B66" ref-type="bibr">66</xref>] and represents the molecular basis of progeroid laminopathies [<xref rid="B59" ref-type="bibr">59</xref>].</p><p>Via interaction with structural and enzymatic molecules, A-type lamins enable several cellular functions, including mechanotransduction [<xref rid="B67" ref-type="bibr">67</xref>], shuttling of proteins from the cytoplasm to the nucleus [<xref rid="B68" ref-type="bibr">68</xref>], and epigenetic modification of chromatin, affecting the expression of proteins involved in the cell cycle and/or differentiation [<xref rid="B69" ref-type="bibr">69</xref>]. The pleiotropic involvement of A-type lamins in all these cellular events explains why mutations in the <italic>LMNA</italic> gene are the cause of a wide number of disorders, collectively known as &#x0201c;laminopathies,&#x0201d; which may affect one or more specific tissues, including skeletal and cardiac muscles, tendons, adipose tissue, and peripheral neurons, or be systemic causing accelerated ageing [<xref rid="B70" ref-type="bibr">70</xref>].</p><p>One of the most important cellular activities affected by <italic>LMNA</italic> mutations is mechanotransduction [<xref rid="B71" ref-type="bibr">71</xref>], a function particularly relevant in striated muscle [<xref rid="B26" ref-type="bibr">26</xref>]. From a molecular point of view, mechanical changes propagate from the cytoskeleton to the nuclear membrane and chromatin through direct interaction between A-type lamins and the LINC (linker of nucleoskeleton and cytoskeleton) complex [<xref rid="B72" ref-type="bibr">72</xref>], which is formed by SUN1 and SUN2 at the inner nuclear membrane and nesprins, which also span the outer nuclear membrane. Nesprins interact with cytoskeletal actin and, by binding to plectin, with microtubules and intermediate filaments [<xref rid="B73" ref-type="bibr">73</xref>]. However, nesprins also interact with lamin A/C [<xref rid="B74" ref-type="bibr">74</xref>]. Mutation of each of the components of the LINC complex negatively affects the functions of this intricate mechanism, resulting in an interruption or an alteration of the modulation of mechanoresponse and mechanotransduction of muscle cells [<xref rid="B75" ref-type="bibr">75</xref>, <xref rid="B76" ref-type="bibr">76</xref>]. Not surprisingly, LINC protein mutations cause muscular dystrophies including Emery-Dreifuss muscular dystrophy (EDMD) [<xref rid="B77" ref-type="bibr">77</xref>&#x02013;<xref rid="B80" ref-type="bibr">80</xref>].</p></sec><sec id="sec4.2"><title>4.2. Muscular Laminopathies</title><p>Mutations in <italic>LMNA</italic> gene cause a variety of muscular diseases including EDMD, limb-girdle muscular dystrophy 1B (LGMD1B), dilated cardiomyopathy with conduction defects (DCM1A), and <italic>LMNA</italic>-related congenital muscular dystrophy (L-CMD) [<xref rid="B60" ref-type="bibr">60</xref>, <xref rid="B81" ref-type="bibr">81</xref>, <xref rid="B82" ref-type="bibr">82</xref>]. Moreover, muscle functionality may be impaired in cases of progeroid laminopathies or lipodystrophies [<xref rid="B59" ref-type="bibr">59</xref>, <xref rid="B83" ref-type="bibr">83</xref>]. The inheritance pattern of <italic>LMNA</italic>-related muscle diseases is autosomal dominant and very rarely autosomal recessive. All these disorders are characterized by joint contractures, muscle weakness and wasting, and dilated cardiomyopathy. The L-CMD onset is at birth, whereas EDMD2 and EDMD3 (respectively, with dominant and recessive inheritance) have an onset in childhood or young adulthood, as most cases of LGMD1B. DCM1A, which is usually diagnosed in the second decade, is often associated with conduction disorders and cardiac arrhythmias with life-threatening outcome requiring defibrillator implantation and, in severe cases, heart transplantation [<xref rid="B81" ref-type="bibr">81</xref>]. Extracardiac features including skeletal muscle weakness and contractures may occur later in DCM1A, causing a phenotype overlapping with EDMD2 [<xref rid="B84" ref-type="bibr">84</xref>].</p></sec><sec id="sec4.3"><title>4.3. Pathogenetic Mechanisms in Muscular Laminopathies</title><p>
<italic>LMNA</italic> gene mutations negatively modulate mechanoresponse and mechanotransduction in muscle cells essentially by two different ways. The first mechanism is related to the structural role played by A-type lamins in the assembly of a molecular platform able to connect and coordinate multiple mechanical and chemical stimuli. The second modality implies alteration of lamin A/C epigenetic activity that results in an abnormal regulation of responsive genes [<xref rid="B65" ref-type="bibr">65</xref>]. Cells lacking A-type lamins or expressing myopathic lamin A mutants show reduced nuclear stiffness and altered nuclear morphology and are unable to transmit forces to the nucleus [<xref rid="B67" ref-type="bibr">67</xref>]. In addition, the localization of various components of the LINC complex is severely disturbed in those cells [<xref rid="B67" ref-type="bibr">67</xref>]. For instance, in EDMD2 myotubes, the mislocalization of SUN1 and SUN2 due to reduced prelamin A interaction was responsible for an altered positioning of myonuclei [<xref rid="B62" ref-type="bibr">62</xref>]. The pathogenetic mechanism also involved mislocalization of the nuclear envelope protein Samp1 and defective interplay with the centrosomal protein pericentrin [<xref rid="B63" ref-type="bibr">63</xref>]. All these findings highlight the prominent role of A-type lamins in nucleocytoskeleton crosstalk. Importantly, it has been demonstrated that upon mechanical stress, the Ig fold domain of lamin A is able to partially unfold, leading to stretching of the entire molecule [<xref rid="B85" ref-type="bibr">85</xref>]. Interestingly, when the extracellular matrix (ECM) increases its stiffness, lamin A undergoes dephosphorylation at Serine 22, a condition enabling increased nuclear stiffness [<xref rid="B86" ref-type="bibr">86</xref>]. It is likely that phosphorylation of other residues of lamin A/C contributes to modulation of nuclear stiffness in response to ECM stimuli [<xref rid="B87" ref-type="bibr">87</xref>&#x02013;<xref rid="B89" ref-type="bibr">89</xref>]. We found that the pathogenicity of an EDMD2-causative lamin A/C mutation, Arg401Cys, is related to impaired phosphorylation of Serine 404 by Akt1 [<xref rid="B90" ref-type="bibr">90</xref>]. It is conceivable that, since phosphorylation of Serine 404 is required for prelamin A and lamin A turnover, impaired phosphorylation might alter nuclear lamina composition and stiffness in response to mechanical stimuli [<xref rid="B90" ref-type="bibr">90</xref>, <xref rid="B91" ref-type="bibr">91</xref>].</p><p>Altered chromatin organization is considered as a main pathogenic condition in muscular laminopathies [<xref rid="B60" ref-type="bibr">60</xref>]. Both high-order chromatin structure [<xref rid="B92" ref-type="bibr">92</xref>] and promoter-specific epigenetic defects lead to altered gene expression, consequently affecting muscle-specific gene expression [<xref rid="B93" ref-type="bibr">93</xref>, <xref rid="B94" ref-type="bibr">94</xref>].</p><p>Another well-documented effect of <italic>LMNA</italic> mutations causing EDMD is altered PI3-kinase-Akt-Erk2 signaling, which has been demonstrated both in patient cells and in mouse models of the disease (reviewed by Brull et al. [<xref rid="B95" ref-type="bibr">95</xref>]). A dramatic effect of this altered signaling has been reported on the cardiac function, and the efficacy of therapies based on inhibition of hyperactivated MAP kinase-Erk1/2 signaling has been experimentally proven [<xref rid="B96" ref-type="bibr">96</xref>]. Of note, TGF-<italic>&#x003b2;</italic> 2 and its downstream effectors are increased in EDMD2 mouse models [<xref rid="B97" ref-type="bibr">97</xref>] as well as in serum and cells from laminopathic patients eliciting upregulation of fibrogenic molecules [<xref rid="B82" ref-type="bibr">82</xref>], a pathogenetic effect relevant to muscle and tendon fibrosis [<xref rid="B82" ref-type="bibr">82</xref>].</p></sec></sec><sec id="sec5"><title>5. Ankrd2 and Lamin in Normal and Laminopathic Muscles</title><p>In C2C12 differentiated muscle cells, oxidative stress generated by exposure to H<sub>2</sub>O<sub>2</sub> induces Akt2 kinase to phosphorylate Ankrd2 at Serine 99 [<xref rid="B15" ref-type="bibr">15</xref>]. By using a phosphorylation-defective mutant form of Ankrd2 (Ankrd2 Ser99Ala), we demonstrated that opposite to its wild-type counterpart, phosphorylation-defective Ankrd2 is unable to translocate into the nucleus upon cellular exposure to oxidative stress [<xref rid="B98" ref-type="bibr">98</xref>]. Importantly, C2C12 myoblasts expressing Ankrd2 Ser99Ala mutant presented a faster differentiation kinetics [<xref rid="B15" ref-type="bibr">15</xref>]. We therefore reasoned that after sensing oxidative stress, Ankrd2 phosphorylation could be required to allow Ankrd2 translocation to the nucleus, where it could participate in the transcriptional modulation of the terminal steps of muscle differentiation. Supporting this hypothesis, we found that Serine 99 is proximal to Ankrd2 NLS (from Lysine 120 to Lysine 123 in the human protein) [<xref rid="B15" ref-type="bibr">15</xref>]. Therefore, although the molecular mechanism underlying Ankrd2 nuclear transport is still unclear, upon ROS stimulation, phosphorylation of Serine 99 might unmask the NLS, allowing Ankrd2 to translocate in the nucleus.</p><p>We have demonstrated that during ROS-induced nuclear relocation, Ankrd2 was complexed to A-type lamins, albeit with different affinities for diverse lamin A isoforms [<xref rid="B98" ref-type="bibr">98</xref>]. During muscle differentiation, prelamin A levels are increased [<xref rid="B61" ref-type="bibr">61</xref>&#x02013;<xref rid="B63" ref-type="bibr">63</xref>], and Ankrd2 interacts with prelamin A with a higher affinity than that established with mature lamin A [<xref rid="B98" ref-type="bibr">98</xref>]. Upon the exposure to ROS, Ankrd2 transiently interacted with lamin A and prelamin A, entered the nucleus, and soon after went back to the cytosol. However, EDMD2-linked lamin A mutants constitutively bound Ankrd2, even in the absence of any stimulus, causing Ankrd2 to be retained in the nucleus [<xref rid="B98" ref-type="bibr">98</xref>]. We therefore suggest that while under physiological conditions, including muscle differentiation or oxidative stress response, Ankrd2 is transiently retained in the nucleus also due to a reversible increase of prelamin A levels [<xref rid="B61" ref-type="bibr">61</xref>, <xref rid="B62" ref-type="bibr">62</xref>, <xref rid="B64" ref-type="bibr">64</xref>, <xref rid="B99" ref-type="bibr">99</xref>], EDMD2-linked lamin A mutants entrap Ankrd2 into the nucleus, affecting its dynamics [<xref rid="B98" ref-type="bibr">98</xref>]. Further experiments performed using cells overexpressing Ankrd2 and EDMD2-lamin A mutants revealed that permanent location of Ankrd2 in the nucleus increased release of cellular ROS, as well as apoptotic cell death [<xref rid="B98" ref-type="bibr">98</xref>]. Similarly, in laminopathic muscle, the effects of permanent Ankrd2 recruitment in the nucleus might be involved in the reduction of the vitality of myofibers, as well as satellite cells, affecting stem cell renewal and muscle regeneration and resulting in poor adaptation to stress stimuli. A model for a proposed Ankrd2 involvement in the pathogenesis of laminopathies is depicted in <xref ref-type="fig" rid="fig3">Figure 3</xref>.</p><p>Although direct observations of Ankrd2 localization and functions in EDMD2 muscle (including nascent, mature, or regenerating fibers) are still missing, we can suppose that the catastrophic effects of mutated A-type lamins in muscular laminopathies might be also due to the altered Ankrd2-lamin A interaction affecting both mechanosensing and transcriptional activity of Ankrd2.</p></sec><sec id="sec6"><title>6. Perspectives for the Study of Lamin A-Ankrd2 Interplay</title><sec id="sec6.1"><title>6.1. Mechanosignaling Regulation through Ankrd2</title><p>Albeit still unexplored, a consequence of an altered nuclear recruitment of Ankrd2 observed in laminopathies might also be related to a reduced availability of cytoplasmic Ankrd2 at the I-bands of the sarcomere and thus to a decreased mechanosensing activity. Therefore, it would be worth evaluating the change in the Ankrd2 amount at the sarcomere in laminopathic conditions. Moreover, given the involvement of lamin A in mechanosignaling through the LINC complex, it would be worth deepening the potential involvement of Ankrd2 in lamin A/LINC complex-dependent mechanisms of response to mechanical strain.</p></sec><sec id="sec6.2"><title>6.2. Muscle Fiber Type Disproportion (FTD)</title><p>Muscle fiber type disproportion (FTD) is a pathological condition in which there is the selective reduction of the size of slow and not fast myofibers. FTD is observed in many cardiac and skeletal muscle disorders, with severe effects on the functionality of all the striated muscle. Interestingly, since Ankrd2 is principally expressed in slow fibers, pathological nuclear recruitment of Ankrd2 might also be involved in the damage and atrophy of slow fibers reported in muscular laminopathies [<xref rid="B100" ref-type="bibr">100</xref>, <xref rid="B101" ref-type="bibr">101</xref>].</p><p>In fact, FTD has been observed in some cases of LGMD1B [<xref rid="B100" ref-type="bibr">100</xref>, <xref rid="B102" ref-type="bibr">102</xref>] as well as EDMD2 [<xref rid="B100" ref-type="bibr">100</xref>]. Furthermore, in skeletal muscle from Lmna<sup>H222P/H222P</sup> mice, in addition to FTD, atrophy of fast fibers was detected [<xref rid="B101" ref-type="bibr">101</xref>].</p></sec><sec id="sec6.3"><title>6.3. PML-NB</title><p>Promyelocytic leukemia protein-nuclear bodies (PML-NBs) are nuclear matrix-associated domains recruiting a variety of seemingly unrelated proteins with the aim of regulating many cellular functions from transcriptional regulation to growth regulation, tumor suppression, apoptosis, and storage of nuclear proteins under stress conditions [<xref rid="B103" ref-type="bibr">103</xref>]. PML-NBs are presumed to mediate protein-protein interactions and function as a platform that promotes protein posttranslational modification, for example, SUMOylation, acetylation, ubiquitination, and phosphorylation [<xref rid="B104" ref-type="bibr">104</xref>]. This has been demonstrated for p53, which is activated in PML-NBs of C2C12 myoblasts, upon exposure to ROS [<xref rid="B105" ref-type="bibr">105</xref>]. Interestingly, both Ankrd2 and lamin A/C bind to PML, a core constituent of PML-NBs, and albeit not essential for PML-NB function, it regulates their development under stress condition [<xref rid="B106" ref-type="bibr">106</xref>]. Since it has been reported that progerin, the truncated and toxic prelamin A responsible for the progeroid disease HGPS, progressively accumulated in PML bodies, altering their shape and number [<xref rid="B107" ref-type="bibr">107</xref>], it is therefore possible that other lamin A/C mutants might participate in the formation of PML-NBs under stress conditions, perturbing their downstream pathways involved in transcription, apoptosis, senescence, response to DNA damage, etc. As already reported, Ankrd2 localizes at PML-NBs under stress conditions [<xref rid="B1" ref-type="bibr">1</xref>]. The possibility that mutant A-type lamins and Ankrd2 localization at the PML-NBs concur to aberrantly regulate PML-NB activity under stress conditions warrants further investigation.</p></sec><sec id="sec6.4"><title>6.4. Therapeutic Perspectives</title><p>Sequestration of proteins at the nuclear envelope or inside the nucleus by lamin mutants as well as by excess levels of wild-type lamins has been widely reported and involves DNA-binding proteins such as BAF and transcription factors such as Oct-1, c-FOS, and AP-1 [<xref rid="B108" ref-type="bibr">108</xref>&#x02013;<xref rid="B118" ref-type="bibr">118</xref>]. An interesting condition has been described in a <italic>Drosophila</italic> model of EDMD2 as well as in patient muscle fibers, where nuclear accumulation of the stress-responsive protein Nrf2 (Nuclear factor erythroid 2-related factor 2) was observed [<xref rid="B119" ref-type="bibr">119</xref>]. It is conceivable that Nrf2 and Ankrd2 aberrant dynamics both contribute to altered stress response in EDMD2. The identification of molecules able to release aberrant interactions between mutated lamins and their binding partners, including Ankrd2, may provide innovative therapeutic tools for laminopathies.</p></sec></sec><sec id="sec7"><title>7. Concluding Remarks</title><p>In conclusion, although direct evidence on Ankrd2 localization in forming, mature, and regenerating EDMD2 muscle fibers is still missing, we hypothesize that alterations in expression, PTMs, interactors, or nuclear localization of Ankrd2 might contribute to impair the response to mechanical and/or oxidative stress. Future studies exploiting different laminopathic animal models, including murine Lmna<sup>H222P/H222P</sup> KI, Lmna<sup>&#x02206;K32</sup> KI, or Lmna KO (respectively, reproducing conditions very close to human cardiomyopathy, L-CMD and EDMD [<xref rid="B101" ref-type="bibr">101</xref>, <xref rid="B120" ref-type="bibr">120</xref>, <xref rid="B121" ref-type="bibr">121</xref>]), would enable further novel insights into the role of Ankrd2 in the pathophysiology of muscular laminopathies.</p><p>Finally, a proteomic analysis of Ankrd2 interactome in mature muscle (healthy and EDMD2-affected), as well as the creation of animal models expressing unphosphorylatable Ankrd2 forms, will help to better define the role of Ankrd2 in muscular tissue, allowing the assignment of a specific role of oxidative stress-dependent phosphorylation to the pathology of other cardiac and skeletal muscle disorders.</p></sec></body><back><ack><title>Acknowledgments</title><p>The authors thank the Italian Network for Laminopathies for discussion and support. The skilled technical assistance of Aurelio Valmori is gratefully acknowledged. V.C. and C.C. are funded by &#x0201c;Associazione Italiana Distrofia Muscolare di Emery-Dreifuss&#x0201d; (AIDMED) onlus and &#x0201c;Associazione Alessandra Proietti Onlus&#x0201d;. G.L. is funded by MIUR PRIN 2015FBNB5Y. SK is supported by the Ministry of Education, Science and Technological Development of the Republic of Serbia, Project No. 173008.</p></ack><sec sec-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflict of interest.</p></sec><sec><title>Authors' Contributions</title><p>All of the authors contributed to the writing and editing of the article.</p></sec><ref-list><ref id="B1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kojic</surname><given-names>S.</given-names></name><name><surname>Medeot</surname><given-names>E.</given-names></name><name><surname>Guccione</surname><given-names>E.</given-names></name><etal/></person-group><article-title>The Ankrd2 protein, a link between the sarcomere and the nucleus in skeletal muscle</article-title><source><italic toggle="yes">Journal of Molecular Biology</italic></source><year>2004</year><volume>339</volume><issue>2</issue><fpage>313</fpage><lpage>325</lpage><pub-id pub-id-type="doi">10.1016/j.jmb.2004.03.071</pub-id><pub-id pub-id-type="other">2-s2.0-2342479800</pub-id><pub-id pub-id-type="pmid">15136035</pub-id></element-citation></ref><ref id="B2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakada</surname><given-names>C.</given-names></name><name><surname>Tsukamoto</surname><given-names>Y.</given-names></name><name><surname>Oka</surname><given-names>A.</given-names></name><etal/></person-group><article-title>Altered expression of ARPP protein in skeletal muscles of patients with muscular dystrophy, congenital myopathy and spinal muscular atrophy</article-title><source><italic toggle="yes">Pathobiology</italic></source><year>2004</year><volume>71</volume><issue>1</issue><fpage>43</fpage><lpage>51</lpage><pub-id pub-id-type="doi">10.1159/000072961</pub-id><pub-id pub-id-type="other">2-s2.0-0141993303</pub-id><pub-id pub-id-type="pmid">14555844</pub-id></element-citation></ref><ref id="B3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nagueh</surname><given-names>S. F.</given-names></name><name><surname>Shah</surname><given-names>G.</given-names></name><name><surname>Wu</surname><given-names>Y.</given-names></name><etal/></person-group><article-title>Altered titin expression, myocardial stiffness, and left ventricular function in patients with dilated cardiomyopathy</article-title><source><italic toggle="yes">Circulation</italic></source><year>2004</year><volume>110</volume><issue>2</issue><fpage>155</fpage><lpage>162</lpage><pub-id pub-id-type="doi">10.1161/01.cir.0000135591.37759.af</pub-id><pub-id pub-id-type="other">2-s2.0-3142672018</pub-id><pub-id pub-id-type="pmid">15238456</pub-id></element-citation></ref><ref id="B4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ishiguro</surname><given-names>N.</given-names></name><name><surname>Baba</surname><given-names>T.</given-names></name><name><surname>Ishida</surname><given-names>T.</given-names></name><etal/></person-group><article-title>Carp, a cardiac ankyrin-repeated protein, and its new homologue, Arpp, are differentially expressed in heart, skeletal muscle, and rhabdomyosarcomas</article-title><source><italic toggle="yes">The American Journal of Pathology</italic></source><year>2002</year><volume>160</volume><issue>5</issue><fpage>1767</fpage><lpage>1778</lpage><pub-id pub-id-type="doi">10.1016/s0002-9440(10)61123-6</pub-id><pub-id pub-id-type="other">2-s2.0-0036098270</pub-id><pub-id pub-id-type="pmid">12000728</pub-id></element-citation></ref><ref id="B5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>M.</given-names></name><name><surname>Muers</surname><given-names>M. R.</given-names></name><name><surname>Lu</surname><given-names>X.</given-names></name></person-group><article-title>Introducing STRaNDs: shuttling transcriptional regulators that are non-DNA binding</article-title><source><italic toggle="yes">Nature Reviews Molecular Cell Biology</italic></source><year>2016</year><volume>17</volume><issue>8</issue><fpage>523</fpage><lpage>532</lpage><pub-id pub-id-type="doi">10.1038/nrm.2016.41</pub-id><pub-id pub-id-type="other">2-s2.0-84969963060</pub-id><pub-id pub-id-type="pmid">27220640</pub-id></element-citation></ref><ref id="B6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wette</surname><given-names>S. G.</given-names></name><name><surname>Smith</surname><given-names>H. K.</given-names></name><name><surname>Lamb</surname><given-names>G. D.</given-names></name><name><surname>Murphy</surname><given-names>R. M.</given-names></name></person-group><article-title>Characterization of muscle ankyrin repeat proteins in human skeletal muscle</article-title><source><italic toggle="yes">American Journal of Physiology-Cell Physiology</italic></source><year>2017</year><volume>313</volume><issue>3</issue><fpage>C327</fpage><lpage>C339</lpage><pub-id pub-id-type="doi">10.1152/ajpcell.00077.2017</pub-id><pub-id pub-id-type="other">2-s2.0-85029232675</pub-id><pub-id pub-id-type="pmid">28615162</pub-id></element-citation></ref><ref id="B7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname><given-names>M. K.</given-names></name><name><surname>Bang</surname><given-names>M.-L.</given-names></name><name><surname>Witt</surname><given-names>C. C.</given-names></name><etal/></person-group><article-title>The muscle ankyrin repeat proteins: CARP, ankrd2/Arpp and DARP as a family of titin filament-based stress response molecules</article-title><source><italic toggle="yes">Journal of Molecular Biology</italic></source><year>2003</year><volume>333</volume><issue>5</issue><fpage>951</fpage><lpage>964</lpage><pub-id pub-id-type="doi">10.1016/j.jmb.2003.09.012</pub-id><pub-id pub-id-type="other">2-s2.0-0142247618</pub-id><pub-id pub-id-type="pmid">14583192</pub-id></element-citation></ref><ref id="B8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsukamoto</surname><given-names>Y.</given-names></name><name><surname>Senda</surname><given-names>T.</given-names></name><name><surname>Nakano</surname><given-names>T.</given-names></name><etal/></person-group><article-title>Arpp, a new homolog of carp, is preferentially expressed in type 1 skeletal muscle fibers and is markedly induced by denervation</article-title><source><italic toggle="yes">Laboratory Investigation</italic></source><year>2002</year><volume>82</volume><issue>5</issue><fpage>645</fpage><lpage>655</lpage><pub-id pub-id-type="doi">10.1038/labinvest.3780459</pub-id><pub-id pub-id-type="other">2-s2.0-18344387677</pub-id><pub-id pub-id-type="pmid">12004005</pub-id></element-citation></ref><ref id="B9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hayashi</surname><given-names>C.</given-names></name><name><surname>Ono</surname><given-names>Y.</given-names></name><name><surname>Doi</surname><given-names>N.</given-names></name><etal/></person-group><article-title>Multiple molecular interactions implicate the connectin/titin N2A region as a modulating scaffold for p94/calpain 3 activity in skeletal muscle</article-title><source><italic toggle="yes">Journal of Biological Chemistry</italic></source><year>2008</year><volume>283</volume><issue>21</issue><fpage>14801</fpage><lpage>14814</lpage><pub-id pub-id-type="doi">10.1074/jbc.M708262200</pub-id><pub-id pub-id-type="other">2-s2.0-47249105570</pub-id><pub-id pub-id-type="pmid">18310072</pub-id></element-citation></ref><ref id="B10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsukamoto</surname><given-names>Y.</given-names></name><name><surname>Hijiya</surname><given-names>N.</given-names></name><name><surname>Yano</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Arpp/Ankrd2, a member of the muscle ankyrin repeat proteins (MARPs), translocates from the I-band to the nucleus after muscle injury</article-title><source><italic toggle="yes">Histochemistry and Cell Biology</italic></source><year>2008</year><volume>129</volume><issue>1</issue><fpage>55</fpage><lpage>64</lpage><pub-id pub-id-type="doi">10.1007/s00418-007-0348-9</pub-id><pub-id pub-id-type="other">2-s2.0-37249018549</pub-id><pub-id pub-id-type="pmid">17926058</pub-id></element-citation></ref><ref id="B11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bean</surname><given-names>C.</given-names></name><name><surname>Facchinello</surname><given-names>N.</given-names></name><name><surname>Faulkner</surname><given-names>G.</given-names></name><name><surname>Lanfranchi</surname><given-names>G.</given-names></name></person-group><article-title>The effects of Ankrd2 alteration indicate its involvement in cell cycle regulation during muscle differentiation</article-title><source><italic toggle="yes">Biochimica et Biophysica Acta</italic></source><year>2008</year><volume>1783</volume><issue>6</issue><fpage>1023</fpage><lpage>1035</lpage><pub-id pub-id-type="doi">10.1016/j.bbamcr.2008.01.027</pub-id><pub-id pub-id-type="other">2-s2.0-43549116105</pub-id><pub-id pub-id-type="pmid">18302940</pub-id></element-citation></ref><ref id="B12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bean</surname><given-names>C.</given-names></name><name><surname>Verma</surname><given-names>N. K.</given-names></name><name><surname>Yamamoto</surname><given-names>D. L.</given-names></name><etal/></person-group><article-title>Ankrd2 is a modulator of NF-<italic>&#x003ba;</italic>B-mediated inflammatory responses during muscle differentiation</article-title><source><italic toggle="yes">Cell Death &#x00026; Disease</italic></source><year>2014</year><volume>5</volume><issue>1, article e1002</issue><pub-id pub-id-type="doi">10.1038/cddis.2013.525</pub-id><pub-id pub-id-type="other">2-s2.0-84899677724</pub-id></element-citation></ref><ref id="B13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mohamed</surname><given-names>J. S.</given-names></name><name><surname>Lopez</surname><given-names>M. A.</given-names></name><name><surname>Cox</surname><given-names>G. A.</given-names></name><name><surname>Boriek</surname><given-names>A. M.</given-names></name></person-group><article-title>Ankyrin repeat domain protein 2 and inhibitor of DNA binding 3 cooperatively inhibit myoblast differentiation by physical interaction</article-title><source><italic toggle="yes">Journal of Biological Chemistry</italic></source><year>2013</year><volume>288</volume><issue>34</issue><fpage>24560</fpage><lpage>24568</lpage><pub-id pub-id-type="doi">10.1074/jbc.M112.434423</pub-id><pub-id pub-id-type="other">2-s2.0-84883202862</pub-id><pub-id pub-id-type="pmid">23824195</pub-id></element-citation></ref><ref id="B14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blais</surname><given-names>A.</given-names></name><name><surname>Tsikitis</surname><given-names>M.</given-names></name><name><surname>Acosta-Alvear</surname><given-names>D.</given-names></name><name><surname>Sharan</surname><given-names>R.</given-names></name><name><surname>Kluger</surname><given-names>Y.</given-names></name><name><surname>Dynlacht</surname><given-names>B. D.</given-names></name></person-group><article-title>An initial blueprint for myogenic differentiation</article-title><source><italic toggle="yes">Genes &#x00026; Development</italic></source><year>2005</year><volume>19</volume><issue>5</issue><fpage>553</fpage><lpage>569</lpage><pub-id pub-id-type="doi">10.1101/gad.1281105</pub-id><pub-id pub-id-type="other">2-s2.0-14644390321</pub-id><pub-id pub-id-type="pmid">15706034</pub-id></element-citation></ref><ref id="B15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cenni</surname><given-names>V.</given-names></name><name><surname>Bavelloni</surname><given-names>A.</given-names></name><name><surname>Beretti</surname><given-names>F.</given-names></name><etal/></person-group><article-title>Ankrd2/ARPP is a novel Akt2 specific substrate and regulates myogenic differentiation upon cellular exposure to H(2)O(2)</article-title><source><italic toggle="yes">Molecular Biology of the Cell</italic></source><year>2011</year><volume>22</volume><issue>16</issue><fpage>2946</fpage><lpage>2956</lpage><pub-id pub-id-type="doi">10.1091/mbc.E10-11-0928</pub-id><pub-id pub-id-type="other">2-s2.0-80051675468</pub-id><pub-id pub-id-type="pmid">21737686</pub-id></element-citation></ref><ref id="B16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kemp</surname><given-names>T. J.</given-names></name><name><surname>Sadusky</surname><given-names>T. J.</given-names></name><name><surname>Saltisi</surname><given-names>F.</given-names></name><etal/></person-group><article-title>Identification of Ankrd2, a novel skeletal muscle gene coding for a stretch-responsive ankyrin-repeat protein</article-title><source><italic toggle="yes">Genomics</italic></source><year>2000</year><volume>66</volume><issue>3</issue><fpage>229</fpage><lpage>241</lpage><pub-id pub-id-type="doi">10.1006/geno.2000.6213</pub-id><pub-id pub-id-type="other">2-s2.0-0034659463</pub-id><pub-id pub-id-type="pmid">10873377</pub-id></element-citation></ref><ref id="B17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Edgerton</surname><given-names>V. R.</given-names></name><name><surname>Smith</surname><given-names>J. L.</given-names></name><name><surname>Simpson</surname><given-names>D. R.</given-names></name></person-group><article-title>Muscle fibre type populations of human leg muscles</article-title><source><italic toggle="yes">The Histochemical Journal</italic></source><year>1975</year><volume>7</volume><issue>3</issue><fpage>259</fpage><lpage>266</lpage><pub-id pub-id-type="doi">10.1007/BF01003594</pub-id><pub-id pub-id-type="other">2-s2.0-0016746337</pub-id><pub-id pub-id-type="pmid">123895</pub-id></element-citation></ref><ref id="B18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jasnic-Savovic</surname><given-names>J.</given-names></name><name><surname>Krause</surname><given-names>S.</given-names></name><name><surname>Savic</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Differential expression and localization of Ankrd2 isoforms in human skeletal and cardiac muscles</article-title><source><italic toggle="yes">Histochemistry and Cell Biology</italic></source><year>2016</year><volume>146</volume><issue>5</issue><fpage>569</fpage><lpage>584</lpage><pub-id pub-id-type="doi">10.1007/s00418-016-1465-0</pub-id><pub-id pub-id-type="other">2-s2.0-84978161931</pub-id><pub-id pub-id-type="pmid">27393496</pub-id></element-citation></ref><ref id="B19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moriyama</surname><given-names>M.</given-names></name><name><surname>Tsukamoto</surname><given-names>Y.</given-names></name><name><surname>Fujiwara</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Identification of a novel human ankyrin-repeated protein homologous to CARP</article-title><source><italic toggle="yes">Biochemical and Biophysical Research Communications</italic></source><year>2001</year><volume>285</volume><issue>3</issue><fpage>715</fpage><lpage>723</lpage><pub-id pub-id-type="doi">10.1006/bbrc.2001.5216</pub-id><pub-id pub-id-type="other">2-s2.0-0034816415</pub-id><pub-id pub-id-type="pmid">11453652</pub-id></element-citation></ref><ref id="B20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Belgrano</surname><given-names>A.</given-names></name><name><surname>Rakicevic</surname><given-names>L.</given-names></name><name><surname>Mittempergher</surname><given-names>L.</given-names></name><etal/></person-group><article-title>Multi-tasking role of the mechanosensing protein Ankrd2 in the signaling network of striated muscle</article-title><source><italic toggle="yes">PLoS One</italic></source><year>2011</year><volume>6</volume><issue>10, article e25519</issue><pub-id pub-id-type="doi">10.1371/journal.pone.0025519</pub-id><pub-id pub-id-type="other">2-s2.0-80053919255</pub-id><pub-id pub-id-type="pmid">22016770</pub-id></element-citation></ref><ref id="B21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kojic</surname><given-names>S.</given-names></name><name><surname>Nestorovic</surname><given-names>A.</given-names></name><name><surname>Rakicevic</surname><given-names>L.</given-names></name><etal/></person-group><article-title>A novel role for cardiac ankyrin repeat protein Ankrd1/CARP as a co-activator of the p53 tumor suppressor protein</article-title><source><italic toggle="yes">Archives of Biochemistry and Biophysics</italic></source><year>2010</year><volume>502</volume><issue>1</issue><fpage>60</fpage><lpage>67</lpage><pub-id pub-id-type="doi">10.1016/j.abb.2010.06.029</pub-id><pub-id pub-id-type="other">2-s2.0-77956182195</pub-id><pub-id pub-id-type="pmid">20599664</pub-id></element-citation></ref><ref id="B22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jasnic-Savovic</surname><given-names>J.</given-names></name><name><surname>Nestorovic</surname><given-names>A.</given-names></name><name><surname>Savic</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Profiling of skeletal muscle Ankrd2 protein in human cardiac tissue and neonatal rat cardiomyocytes</article-title><source><italic toggle="yes">Histochemistry and Cell Biology</italic></source><year>2015</year><volume>143</volume><issue>6</issue><fpage>583</fpage><lpage>597</lpage><pub-id pub-id-type="doi">10.1007/s00418-015-1307-5</pub-id><pub-id pub-id-type="other">2-s2.0-84929841130</pub-id><pub-id pub-id-type="pmid">25585647</pub-id></element-citation></ref><ref id="B23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bang</surname><given-names>M. L.</given-names></name><name><surname>Gu</surname><given-names>Y.</given-names></name><name><surname>Dalton</surname><given-names>N. D.</given-names></name><name><surname>Peterson</surname><given-names>K. L.</given-names></name><name><surname>Chien</surname><given-names>K. R.</given-names></name><name><surname>Chen</surname><given-names>J.</given-names></name></person-group><article-title>The muscle ankyrin repeat proteins CARP, Ankrd2, and DARP are not essential for normal cardiac development and function at basal conditions and in response to pressure overload</article-title><source><italic toggle="yes">PLoS One</italic></source><year>2014</year><volume>9</volume><issue>4, article e93638</issue><pub-id pub-id-type="doi">10.1371/journal.pone.0093638</pub-id><pub-id pub-id-type="other">2-s2.0-84899676623</pub-id><pub-id pub-id-type="pmid">24736439</pub-id></element-citation></ref><ref id="B24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Song</surname><given-names>Y.</given-names></name><name><surname>Xu</surname><given-names>J.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><etal/></person-group><article-title>Cardiac Ankyrin Repeat Protein Attenuates Cardiac Hypertrophy by Inhibition of ERK1/2 and TGF-<italic>&#x003b2;</italic> Signaling Pathways</article-title><source><italic toggle="yes">PLoS One</italic></source><year>2012</year><volume>7</volume><issue>12, article e50436</issue><pub-id pub-id-type="doi">10.1371/journal.pone.0050436</pub-id><pub-id pub-id-type="other">2-s2.0-84870855770</pub-id><pub-id pub-id-type="pmid">23227174</pub-id></element-citation></ref><ref id="B25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bogomolovas</surname><given-names>J.</given-names></name><name><surname>Brohm</surname><given-names>K.</given-names></name><name><surname>Celutkiene</surname><given-names>J.</given-names></name><etal/></person-group><article-title>Induction of Ankrd1 in dilated cardiomyopathy correlates with the heart failure progression</article-title><source><italic toggle="yes">BioMed Research International</italic></source><year>2015</year><volume>2015</volume><fpage>9</fpage><pub-id pub-id-type="publisher-id">273936</pub-id><pub-id pub-id-type="doi">10.1155/2015/273936</pub-id><pub-id pub-id-type="other">2-s2.0-84928966508</pub-id><pub-id pub-id-type="pmid">25961010</pub-id></element-citation></ref><ref id="B26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dahl</surname><given-names>K. N.</given-names></name><name><surname>Ribeiro</surname><given-names>A. J. S.</given-names></name><name><surname>Lammerding</surname><given-names>J.</given-names></name></person-group><article-title>Nuclear shape, mechanics, and mechanotransduction</article-title><source><italic toggle="yes">Circulation Research</italic></source><year>2008</year><volume>102</volume><issue>11</issue><fpage>1307</fpage><lpage>1318</lpage><pub-id pub-id-type="doi">10.1161/CIRCRESAHA.108.173989</pub-id><pub-id pub-id-type="other">2-s2.0-44949118668</pub-id><pub-id pub-id-type="pmid">18535268</pub-id></element-citation></ref><ref id="B27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tskhovrebova</surname><given-names>L.</given-names></name><name><surname>Trinick</surname><given-names>J.</given-names></name></person-group><article-title>Titin: properties and family relationships</article-title><source><italic toggle="yes">Nature Reviews Molecular Cell Biology</italic></source><year>2003</year><volume>4</volume><issue>9</issue><fpage>679</fpage><lpage>689</lpage><pub-id pub-id-type="doi">10.1038/nrm1198</pub-id><pub-id pub-id-type="other">2-s2.0-0042839620</pub-id><pub-id pub-id-type="pmid">14506471</pub-id></element-citation></ref><ref id="B28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hackman</surname><given-names>P.</given-names></name><name><surname>Marchand</surname><given-names>S.</given-names></name><name><surname>Sarparanta</surname><given-names>J.</given-names></name><etal/></person-group><article-title>Truncating mutations in C-terminal titin may cause more severe tibial muscular dystrophy (TMD)</article-title><source><italic toggle="yes">Neuromuscular Disorders</italic></source><year>2008</year><volume>18</volume><issue>12</issue><fpage>922</fpage><lpage>928</lpage><pub-id pub-id-type="doi">10.1016/j.nmd.2008.07.010</pub-id><pub-id pub-id-type="other">2-s2.0-56949093246</pub-id><pub-id pub-id-type="pmid">18948003</pub-id></element-citation></ref><ref id="B29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Udd</surname><given-names>B.</given-names></name><name><surname>Vihola</surname><given-names>A.</given-names></name><name><surname>Sarparanta</surname><given-names>J.</given-names></name><name><surname>Richard</surname><given-names>I.</given-names></name><name><surname>Hackman</surname><given-names>P.</given-names></name></person-group><article-title>Titinopathies and extension of the M-line mutation phenotype beyond distal myopathy and LGMD2J</article-title><source><italic toggle="yes">Neurology</italic></source><year>2005</year><volume>64</volume><issue>4</issue><fpage>636</fpage><lpage>642</lpage><pub-id pub-id-type="doi">10.1212/01.wnl.0000151853.50144.82</pub-id><pub-id pub-id-type="other">2-s2.0-13844311060</pub-id><pub-id pub-id-type="pmid">15728284</pub-id></element-citation></ref><ref id="B30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martinelli</surname><given-names>V. C.</given-names></name><name><surname>Kyle</surname><given-names>W. B.</given-names></name><name><surname>Kojic</surname><given-names>S.</given-names></name><etal/></person-group><article-title>ZASP interacts with the mechanosensing protein Ankrd2 and p53 in the signalling network of striated muscle</article-title><source><italic toggle="yes">PLoS One</italic></source><year>2014</year><volume>9</volume><issue>3, article e92259</issue><pub-id pub-id-type="doi">10.1371/journal.pone.0092259</pub-id><pub-id pub-id-type="other">2-s2.0-84898670868</pub-id><pub-id pub-id-type="pmid">24647531</pub-id></element-citation></ref><ref id="B31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Piatkov</surname><given-names>K. I.</given-names></name><name><surname>Oh</surname><given-names>J.-H.</given-names></name><name><surname>Liu</surname><given-names>Y.</given-names></name><name><surname>Varshavsky</surname><given-names>A.</given-names></name></person-group><article-title>Calpain-generated natural protein fragments as short-lived substrates of the N-end rule pathway</article-title><source><italic toggle="yes">Proceedings of the National Academy of Sciences</italic></source><year>2014</year><volume>111</volume><issue>9</issue><fpage>E817</fpage><lpage>E826</lpage><pub-id pub-id-type="doi">10.1073/pnas.1401639111</pub-id><pub-id pub-id-type="other">2-s2.0-84895826235</pub-id><pub-id pub-id-type="pmid">24550490</pub-id></element-citation></ref><ref id="B32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murphy</surname><given-names>R. M.</given-names></name><name><surname>Lamb</surname><given-names>G. D.</given-names></name></person-group><article-title>Endogenous calpain-3 activation is primarily governed by small increases in resting cytoplasmic [Ca2+] and is not dependent on stretch</article-title><source><italic toggle="yes">Journal of Biological Chemistry</italic></source><year>2009</year><volume>284</volume><issue>12</issue><fpage>7811</fpage><lpage>7819</lpage><pub-id pub-id-type="doi">10.1074/jbc.m808655200</pub-id><pub-id pub-id-type="other">2-s2.0-65549087562</pub-id><pub-id pub-id-type="pmid">19144634</pub-id></element-citation></ref><ref id="B33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ojima</surname><given-names>K.</given-names></name><name><surname>Kawabata</surname><given-names>Y.</given-names></name><name><surname>Nakao</surname><given-names>H.</given-names></name><etal/></person-group><article-title>Dynamic distribution of muscle-specific calpain in mice has a key role in physical-stress adaptation and is impaired in muscular dystrophy</article-title><source><italic toggle="yes">Journal of Clinical Investigation</italic></source><year>2010</year><volume>120</volume><issue>8</issue><fpage>2672</fpage><lpage>2683</lpage><pub-id pub-id-type="doi">10.1172/jci40658</pub-id><pub-id pub-id-type="other">2-s2.0-77955298542</pub-id><pub-id pub-id-type="pmid">20592470</pub-id></element-citation></ref><ref id="B34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garvey</surname><given-names>S. M.</given-names></name><name><surname>Rajan</surname><given-names>C.</given-names></name><name><surname>Lerner</surname><given-names>A. P.</given-names></name><name><surname>Frankel</surname><given-names>W. N.</given-names></name><name><surname>Cox</surname><given-names>G. A.</given-names></name></person-group><article-title>The muscular dystrophy with myositis (mdm) mouse mutation disrupts a skeletal muscle-specific domain of titin</article-title><source><italic toggle="yes">Genomics</italic></source><year>2002</year><volume>79</volume><issue>2</issue><fpage>146</fpage><lpage>149</lpage><pub-id pub-id-type="doi">10.1006/geno.2002.6685</pub-id><pub-id pub-id-type="other">2-s2.0-0035707910</pub-id><pub-id pub-id-type="pmid">11829483</pub-id></element-citation></ref><ref id="B35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mues</surname><given-names>A.</given-names></name><name><surname>van der Ven</surname><given-names>P. F. M.</given-names></name><name><surname>Young</surname><given-names>P.</given-names></name><name><surname>F&#x000fc;rst</surname><given-names>D. O.</given-names></name><name><surname>Gautel</surname><given-names>M.</given-names></name></person-group><article-title>Two immunoglobulin-like domains of the Z-disc portion of titin interact in a conformation-dependent way with telethonin</article-title><source><italic toggle="yes">FEBS Letters</italic></source><year>1998</year><volume>428</volume><issue>1-2</issue><fpage>111</fpage><lpage>114</lpage><pub-id pub-id-type="doi">10.1016/S0014-5793(98)00501-8</pub-id><pub-id pub-id-type="other">2-s2.0-0032557642</pub-id><pub-id pub-id-type="pmid">9645487</pub-id></element-citation></ref><ref id="B36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moreira</surname><given-names>E. S.</given-names></name><name><surname>Wiltshire</surname><given-names>T. J.</given-names></name><name><surname>Faulkner</surname><given-names>G.</given-names></name><etal/></person-group><article-title>Limb-girdle muscular dystrophy type 2G is caused by mutations in the gene encoding the sarcomeric protein telethonin</article-title><source><italic toggle="yes">Nature Genetics</italic></source><year>2000</year><volume>24</volume><issue>2</issue><fpage>163</fpage><lpage>166</lpage><pub-id pub-id-type="doi">10.1038/72822</pub-id><pub-id pub-id-type="other">2-s2.0-0033954004</pub-id><pub-id pub-id-type="pmid">10655062</pub-id></element-citation></ref><ref id="B37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bang</surname><given-names>M.-L.</given-names></name><name><surname>Mudry</surname><given-names>R. E.</given-names></name><name><surname>McElhinny</surname><given-names>A. S.</given-names></name><etal/></person-group><article-title>Myopalladin, a novel 145-kilodalton sarcomeric protein with multiple roles in Z-disc and I-band protein assemblies</article-title><source><italic toggle="yes">The Journal of Cell Biology</italic></source><year>2001</year><volume>153</volume><issue>2</issue><fpage>413</fpage><lpage>428</lpage><pub-id pub-id-type="doi">10.1083/jcb.153.2.413</pub-id><pub-id pub-id-type="other">2-s2.0-0035897410</pub-id><pub-id pub-id-type="pmid">11309420</pub-id></element-citation></ref><ref id="B38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gontier</surname><given-names>Y.</given-names></name></person-group><article-title>The Z-disc proteins myotilin and FATZ-1 interact with each other and are connected to the sarcolemma via muscle-specific filamins</article-title><source><italic toggle="yes">Journal of Cell Science</italic></source><year>2005</year><volume>118</volume><issue>16</issue><fpage>3739</fpage><lpage>3749</lpage><pub-id pub-id-type="doi">10.1242/jcs.02484</pub-id><pub-id pub-id-type="other">2-s2.0-24944550989</pub-id><pub-id pub-id-type="pmid">16076904</pub-id></element-citation></ref><ref id="B39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kr&#x000fc;ger</surname><given-names>M.</given-names></name><name><surname>K&#x000f6;tter</surname><given-names>S.</given-names></name></person-group><article-title>Titin, a central mediator for hypertrophic signaling, exercise-induced mechanosignaling and skeletal muscle remodeling</article-title><source><italic toggle="yes">Frontiers in Physiology</italic></source><year>2016</year><volume>7</volume><fpage>p. 76</fpage><pub-id pub-id-type="doi">10.3389/fphys.2016.00076</pub-id><pub-id pub-id-type="other">2-s2.0-84973160648</pub-id></element-citation></ref><ref id="B40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tian</surname><given-names>L.-F.</given-names></name><name><surname>Li</surname><given-names>H.-Y.</given-names></name><name><surname>Jin</surname><given-names>B.-F.</given-names></name><etal/></person-group><article-title>MDM2 interacts with and downregulates a sarcomeric protein, TCAP</article-title><source><italic toggle="yes">Biochemical and Biophysical Research Communications</italic></source><year>2006</year><volume>345</volume><issue>1</issue><fpage>355</fpage><lpage>361</lpage><pub-id pub-id-type="doi">10.1016/j.bbrc.2006.04.108</pub-id><pub-id pub-id-type="other">2-s2.0-33646391986</pub-id><pub-id pub-id-type="pmid">16678796</pub-id></element-citation></ref><ref id="B41"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McElhinny</surname><given-names>A. S.</given-names></name><name><surname>Kakinuma</surname><given-names>K.</given-names></name><name><surname>Sorimachi</surname><given-names>H.</given-names></name><name><surname>Labeit</surname><given-names>S.</given-names></name><name><surname>Gregorio</surname><given-names>C. C.</given-names></name></person-group><article-title>Muscle-specific RING finger-1 interacts with titin to regulate sarcomeric M-line and thick filament structure and may have nuclear functions via its interaction with glucocorticoid modulatory element binding protein-1</article-title><source><italic toggle="yes">The Journal of Cell Biology</italic></source><year>2002</year><volume>157</volume><issue>1</issue><fpage>125</fpage><lpage>136</lpage><pub-id pub-id-type="doi">10.1083/jcb.200108089</pub-id><pub-id pub-id-type="other">2-s2.0-0036544533</pub-id><pub-id pub-id-type="pmid">11927605</pub-id></element-citation></ref><ref id="B42"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lange</surname><given-names>S.</given-names></name></person-group><article-title>The kinase domain of titin controls muscle gene expression and protein turnover</article-title><source><italic toggle="yes">Science</italic></source><year>2005</year><volume>308</volume><issue>5728</issue><fpage>1599</fpage><lpage>1603</lpage><pub-id pub-id-type="doi">10.1126/science.1110463</pub-id><pub-id pub-id-type="other">2-s2.0-20644440418</pub-id><pub-id pub-id-type="pmid">15802564</pub-id></element-citation></ref><ref id="B43"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gomes</surname><given-names>E. C.</given-names></name><name><surname>Silva</surname><given-names>A. N.</given-names></name><name><surname>de Oliveira</surname><given-names>M. R.</given-names></name></person-group><article-title>Oxidants, antioxidants, and the beneficial roles of exercise-induced production of reactive species</article-title><source><italic toggle="yes">Oxidative Medicine and Cellular Longevity</italic></source><year>2012</year><volume>2012</volume><fpage>12</fpage><pub-id pub-id-type="publisher-id">756132</pub-id><pub-id pub-id-type="doi">10.1155/2012/756132</pub-id><pub-id pub-id-type="other">2-s2.0-84863667206</pub-id><pub-id pub-id-type="pmid">22701757</pub-id></element-citation></ref><ref id="B44"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zuo</surname><given-names>L.</given-names></name><name><surname>Zhou</surname><given-names>T.</given-names></name><name><surname>Pannell</surname><given-names>B. K.</given-names></name><name><surname>Ziegler</surname><given-names>A. C.</given-names></name><name><surname>Best</surname><given-names>T. M.</given-names></name></person-group><article-title>Biological and physiological role of reactive oxygen species &#x02013; the good, the bad and the ugly</article-title><source><italic toggle="yes">Acta Physiologica</italic></source><year>2015</year><volume>214</volume><issue>3</issue><fpage>329</fpage><lpage>348</lpage><pub-id pub-id-type="doi">10.1111/apha.12515</pub-id><pub-id pub-id-type="other">2-s2.0-84930930156</pub-id><pub-id pub-id-type="pmid">25912260</pub-id></element-citation></ref><ref id="B45"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zamir</surname><given-names>O.</given-names></name><name><surname>Hasselgren</surname><given-names>P. O.</given-names></name><name><surname>von Allmen</surname><given-names>D.</given-names></name><name><surname>Fischer</surname><given-names>J. E.</given-names></name></person-group><article-title>In vivo administration of interleukin-1 alpha induces muscle proteolysis in normal and adrenalectomized rats</article-title><source><italic toggle="yes">Metabolism</italic></source><year>1993</year><volume>42</volume><issue>2</issue><fpage>204</fpage><lpage>208</lpage><pub-id pub-id-type="doi">10.1016/0026-0495(93)90036-N</pub-id><pub-id pub-id-type="other">2-s2.0-0027456605</pub-id><pub-id pub-id-type="pmid">8474317</pub-id></element-citation></ref><ref id="B46"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mckoy</surname><given-names>G.</given-names></name><name><surname>Hou</surname><given-names>Y.</given-names></name><name><surname>Yang</surname><given-names>S. Y.</given-names></name><etal/></person-group><article-title>Expression of Ankrd2 in fast and slow muscles and its response to stretch are consistent with a role in slow muscle function</article-title><source><italic toggle="yes">Journal of Applied Physiology</italic></source><year>2005</year><volume>98</volume><issue>6</issue><fpage>2337</fpage><lpage>2343</lpage><pub-id pub-id-type="doi">10.1152/japplphysiol.01046.2004</pub-id><pub-id pub-id-type="other">2-s2.0-19444383095</pub-id><pub-id pub-id-type="pmid">15677738</pub-id></element-citation></ref><ref id="B47"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lehti</surname><given-names>M.</given-names></name><name><surname>Kivel&#x000e4;</surname><given-names>R.</given-names></name><name><surname>Komi</surname><given-names>P.</given-names></name><name><surname>Komulainen</surname><given-names>J.</given-names></name><name><surname>Kainulainen</surname><given-names>H.</given-names></name><name><surname>Kyr&#x000f6;l&#x000e4;inen</surname><given-names>H.</given-names></name></person-group><article-title>Effects of fatiguing jumping exercise on mRNA expression of titin-complex proteins and calpains</article-title><source><italic toggle="yes">Journal of Applied Physiology</italic></source><year>2009</year><volume>106</volume><issue>4</issue><fpage>1419</fpage><lpage>1424</lpage><pub-id pub-id-type="doi">10.1152/japplphysiol.90660.2008</pub-id><pub-id pub-id-type="other">2-s2.0-66149156297</pub-id><pub-id pub-id-type="pmid">19150862</pub-id></element-citation></ref><ref id="B48"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koskinen</surname><given-names>S. O. A.</given-names></name><name><surname>Kyrolainen</surname><given-names>H.</given-names></name><name><surname>Flink</surname><given-names>R.</given-names></name><etal/></person-group><article-title>Human skeletal muscle type 1 fibre distribution and response of stress-sensing proteins along the titin molecule after submaximal exhaustive exercise</article-title><source><italic toggle="yes">Histochemistry and Cell Biology</italic></source><year>2017</year><volume>148</volume><issue>5</issue><fpage>545</fpage><lpage>555</lpage><pub-id pub-id-type="doi">10.1007/s00418-017-1595-z</pub-id><pub-id pub-id-type="other">2-s2.0-85023743696</pub-id><pub-id pub-id-type="pmid">28712031</pub-id></element-citation></ref><ref id="B49"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barash</surname><given-names>I. A.</given-names></name><name><surname>Mathew</surname><given-names>L.</given-names></name><name><surname>Ryan</surname><given-names>A. F.</given-names></name><name><surname>Chen</surname><given-names>J.</given-names></name><name><surname>Lieber</surname><given-names>R. L.</given-names></name></person-group><article-title>Rapid muscle-specific gene expression changes after a single bout of eccentric contractions in the mouse</article-title><source><italic toggle="yes">American Journal of Physiology-Cell Physiology</italic></source><year>2004</year><volume>286</volume><issue>2</issue><fpage>C355</fpage><lpage>C364</lpage><pub-id pub-id-type="doi">10.1152/ajpcell.00211.2003</pub-id><pub-id pub-id-type="pmid">14561590</pub-id></element-citation></ref><ref id="B50"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hentzen</surname><given-names>E. R.</given-names></name><name><surname>Lahey</surname><given-names>M.</given-names></name><name><surname>Peters</surname><given-names>D.</given-names></name><etal/></person-group><article-title>Stress-dependent and -independent expression of the myogenic regulatory factors and the MARP genes after eccentric contractions in rats</article-title><source><italic toggle="yes">The Journal of Physiology</italic></source><year>2006</year><volume>570</volume><issue>1</issue><fpage>157</fpage><lpage>167</lpage><pub-id pub-id-type="doi">10.1113/jphysiol.2005.093005</pub-id><pub-id pub-id-type="other">2-s2.0-33645944669</pub-id><pub-id pub-id-type="pmid">16239282</pub-id></element-citation></ref><ref id="B51"><label>51</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roberts</surname><given-names>M. D.</given-names></name><name><surname>Childs</surname><given-names>T. E.</given-names></name><name><surname>Brown</surname><given-names>J. D.</given-names></name><name><surname>Davis</surname><given-names>J. W.</given-names></name><name><surname>Booth</surname><given-names>F. W.</given-names></name></person-group><article-title>Early depression of Ankrd2 and Csrp3 mRNAs in the polyribosomal and whole tissue fractions in skeletal muscle with decreased voluntary running</article-title><source><italic toggle="yes">Journal of Applied Physiology</italic></source><year>2012</year><volume>112</volume><issue>8</issue><fpage>1291</fpage><lpage>1299</lpage><pub-id pub-id-type="doi">10.1152/japplphysiol.01419.2011</pub-id><pub-id pub-id-type="other">2-s2.0-84860343754</pub-id><pub-id pub-id-type="pmid">22282489</pub-id></element-citation></ref><ref id="B52"><label>52</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pattison</surname><given-names>J. S.</given-names></name><name><surname>Folk</surname><given-names>L. C.</given-names></name><name><surname>Madsen</surname><given-names>R. W.</given-names></name><name><surname>Childs</surname><given-names>T. E.</given-names></name><name><surname>Spangenburg</surname><given-names>E. E.</given-names></name><name><surname>Booth</surname><given-names>F. W.</given-names></name></person-group><article-title>Expression profiling identifies dysregulation of myosin heavy chains IIb and IIx during limb immobilization in the soleus muscles of old rats</article-title><source><italic toggle="yes">The Journal of Physiology</italic></source><year>2003</year><volume>553</volume><issue>2</issue><fpage>357</fpage><lpage>368</lpage><pub-id pub-id-type="doi">10.1113/jphysiol.2003.047233</pub-id><pub-id pub-id-type="other">2-s2.0-0348133552</pub-id><pub-id pub-id-type="pmid">12963800</pub-id></element-citation></ref><ref id="B53"><label>53</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boskovic</surname><given-names>S.</given-names></name><name><surname>Marin-Juez</surname><given-names>R.</given-names></name><name><surname>Jasnic</surname><given-names>J.</given-names></name><etal/></person-group><article-title>Characterization of zebrafish (Danio rerio) muscle ankyrin repeat proteins reveals their conserved response to endurance exercise</article-title><source><italic toggle="yes">PLoS One</italic></source><year>2018</year><volume>13</volume><issue>9, article e0204312</issue><pub-id pub-id-type="doi">10.1371/journal.pone.0204312</pub-id><pub-id pub-id-type="other">2-s2.0-85054023264</pub-id><pub-id pub-id-type="pmid">30252882</pub-id></element-citation></ref><ref id="B54"><label>54</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wei</surname><given-names>Y.</given-names></name><name><surname>Chen</surname><given-names>K.</given-names></name><name><surname>Whaley-Connell</surname><given-names>A. T.</given-names></name><name><surname>Stump</surname><given-names>C. S.</given-names></name><name><surname>Ibdah</surname><given-names>J. A.</given-names></name><name><surname>Sowers</surname><given-names>J. R.</given-names></name></person-group><article-title>Skeletal muscle insulin resistance: role of inflammatory cytokines and reactive oxygen species</article-title><source><italic toggle="yes">American Journal of Physiology-Regulatory, Integrative and Comparative Physiology</italic></source><year>2008</year><volume>294</volume><issue>3</issue><fpage>R673</fpage><lpage>R680</lpage><pub-id pub-id-type="doi">10.1152/ajpregu.00561.2007</pub-id><pub-id pub-id-type="other">2-s2.0-40449086344</pub-id></element-citation></ref><ref id="B55"><label>55</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mohamed</surname><given-names>J. S.</given-names></name><name><surname>Lopez</surname><given-names>M. A.</given-names></name><name><surname>Cox</surname><given-names>G. A.</given-names></name><name><surname>Boriek</surname><given-names>A. M.</given-names></name></person-group><article-title>Anisotropic regulation of Ankrd2 gene expression in skeletal muscle by mechanical stretch</article-title><source><italic toggle="yes">The FASEB Journal</italic></source><year>2010</year><volume>24</volume><issue>9</issue><fpage>3330</fpage><lpage>3340</lpage><pub-id pub-id-type="doi">10.1096/fj.10-158386</pub-id><pub-id pub-id-type="other">2-s2.0-77956644634</pub-id><pub-id pub-id-type="pmid">20442316</pub-id></element-citation></ref><ref id="B56"><label>56</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barash</surname><given-names>I. A.</given-names></name><name><surname>Bang</surname><given-names>M.-L.</given-names></name><name><surname>Mathew</surname><given-names>L.</given-names></name><name><surname>Greaser</surname><given-names>M. L.</given-names></name><name><surname>Chen</surname><given-names>J.</given-names></name><name><surname>Lieber</surname><given-names>R. L.</given-names></name></person-group><article-title>Structural and regulatory roles of muscle ankyrin repeat protein family in skeletal muscle</article-title><source><italic toggle="yes">American Journal of Physiology-Cell Physiology</italic></source><year>2007</year><volume>293</volume><issue>1</issue><fpage>C218</fpage><lpage>C227</lpage><pub-id pub-id-type="doi">10.1152/ajpcell.00055.2007</pub-id><pub-id pub-id-type="other">2-s2.0-34547094568</pub-id><pub-id pub-id-type="pmid">17392382</pub-id></element-citation></ref><ref id="B57"><label>57</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peterson</surname><given-names>J. M.</given-names></name><name><surname>Bakkar</surname><given-names>N.</given-names></name><name><surname>Guttridge</surname><given-names>D. C.</given-names></name></person-group><article-title>NF-<italic>&#x003ba;</italic>B signaling in skeletal muscle health and disease</article-title><source><italic toggle="yes">Current Topics in Developmental Biology</italic></source><year>2011</year><volume>96</volume><fpage>85</fpage><lpage>119</lpage><pub-id pub-id-type="doi">10.1016/b978-0-12-385940-2.00004-8</pub-id><pub-id pub-id-type="other">2-s2.0-79957511355</pub-id><pub-id pub-id-type="pmid">21621068</pub-id></element-citation></ref><ref id="B58"><label>58</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Belizario</surname><given-names>J. E.</given-names></name><name><surname>Fontes-Oliveira</surname><given-names>C. C.</given-names></name><name><surname>Borges</surname><given-names>J. P.</given-names></name><name><surname>Kashiabara</surname><given-names>J. A.</given-names></name><name><surname>Vannier</surname><given-names>E.</given-names></name></person-group><article-title>Skeletal muscle wasting and renewal: a pivotal role of myokine IL-6</article-title><source><italic toggle="yes">SpringerPlus</italic></source><year>2016</year><volume>5</volume><issue>1</issue><fpage>p. 619</fpage><pub-id pub-id-type="doi">10.1186/s40064-016-2197-2</pub-id><pub-id pub-id-type="other">2-s2.0-84969802025</pub-id></element-citation></ref><ref id="B59"><label>59</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cenni</surname><given-names>V.</given-names></name><name><surname>D&#x02019;Apice</surname><given-names>M. R.</given-names></name><name><surname>Garagnani</surname><given-names>P.</given-names></name><etal/></person-group><article-title>Mandibuloacral dysplasia: a premature ageing disease with aspects of physiological ageing</article-title><source><italic toggle="yes">Ageing Research Reviews</italic></source><year>2018</year><volume>42</volume><fpage>1</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.1016/j.arr.2017.12.001</pub-id><pub-id pub-id-type="other">2-s2.0-85037660230</pub-id><pub-id pub-id-type="pmid">29208544</pub-id></element-citation></ref><ref id="B60"><label>60</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Camozzi</surname><given-names>D.</given-names></name><name><surname>Capanni</surname><given-names>C.</given-names></name><name><surname>Cenni</surname><given-names>V.</given-names></name><etal/></person-group><article-title>Diverse lamin-dependent mechanisms interact to control chromatin dynamics</article-title><source><italic toggle="yes">Nucleus</italic></source><year>2014</year><volume>5</volume><issue>5</issue><fpage>427</fpage><lpage>440</lpage><pub-id pub-id-type="doi">10.4161/nucl.36289</pub-id><pub-id pub-id-type="other">2-s2.0-84964313439</pub-id><pub-id pub-id-type="pmid">25482195</pub-id></element-citation></ref><ref id="B61"><label>61</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Capanni</surname><given-names>C.</given-names></name><name><surname>Del Coco</surname><given-names>R.</given-names></name><name><surname>Squarzoni</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Prelamin A is involved in early steps of muscle differentiation</article-title><source><italic toggle="yes">Experimental Cell Research</italic></source><year>2008</year><volume>314</volume><issue>20</issue><fpage>3628</fpage><lpage>3637</lpage><pub-id pub-id-type="doi">10.1016/j.yexcr.2008.09.026</pub-id><pub-id pub-id-type="other">2-s2.0-56249094179</pub-id><pub-id pub-id-type="pmid">18951892</pub-id></element-citation></ref><ref id="B62"><label>62</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mattioli</surname><given-names>E.</given-names></name><name><surname>Columbaro</surname><given-names>M.</given-names></name><name><surname>Capanni</surname><given-names>C.</given-names></name><etal/></person-group><article-title>Prelamin A-mediated recruitment of SUN1 to the nuclear envelope directs nuclear positioning in human muscle</article-title><source><italic toggle="yes">Cell Death &#x00026; Differentiation</italic></source><year>2011</year><volume>18</volume><issue>8</issue><fpage>1305</fpage><lpage>1315</lpage><pub-id pub-id-type="doi">10.1038/cdd.2010.183</pub-id><pub-id pub-id-type="other">2-s2.0-79960238889</pub-id><pub-id pub-id-type="pmid">21311568</pub-id></element-citation></ref><ref id="B63"><label>63</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mattioli</surname><given-names>E.</given-names></name><name><surname>Columbaro</surname><given-names>M.</given-names></name><name><surname>Jafferali</surname><given-names>M. H.</given-names></name><name><surname>Schena</surname><given-names>E.</given-names></name><name><surname>Hallberg</surname><given-names>E.</given-names></name><name><surname>Lattanzi</surname><given-names>G.</given-names></name></person-group><article-title>Samp1 mislocalization in Emery-Dreifuss muscular dystrophy</article-title><source><italic toggle="yes">Cells</italic></source><year>2018</year><volume>7</volume><issue>10</issue><fpage>p. 170</fpage><pub-id pub-id-type="doi">10.3390/cells7100170</pub-id><pub-id pub-id-type="pmid">30326651</pub-id></element-citation></ref><ref id="B64"><label>64</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lattanzi</surname><given-names>G.</given-names></name><name><surname>Ortolani</surname><given-names>M.</given-names></name><name><surname>Columbaro</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Lamins are rapamycin targets that impact human longevity: a study in centenarians</article-title><source><italic toggle="yes">Journal of Cell Science</italic></source><year>2014</year><volume>127</volume><issue>1</issue><fpage>147</fpage><lpage>157</lpage><pub-id pub-id-type="doi">10.1242/jcs.133983</pub-id><pub-id pub-id-type="other">2-s2.0-84891441519</pub-id><pub-id pub-id-type="pmid">24155329</pub-id></element-citation></ref><ref id="B65"><label>65</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mattioli</surname><given-names>E.</given-names></name><name><surname>Andrenacci</surname><given-names>D.</given-names></name><name><surname>Garofalo</surname><given-names>C.</given-names></name><etal/></person-group><article-title>Altered modulation of lamin A/C-HDAC2 interaction and p21 expression during oxidative stress response in HGPS</article-title><source><italic toggle="yes">Aging Cell</italic></source><year>2018</year><volume>17</volume><issue>5, article e12824</issue><pub-id pub-id-type="doi">10.1111/acel.12824</pub-id><pub-id pub-id-type="other">2-s2.0-85052612287</pub-id><pub-id pub-id-type="pmid">30109767</pub-id></element-citation></ref><ref id="B66"><label>66</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Y.</given-names></name><name><surname>Drozdov</surname><given-names>I.</given-names></name><name><surname>Shroff</surname><given-names>R.</given-names></name><name><surname>Beltran</surname><given-names>L. E.</given-names></name><name><surname>Shanahan</surname><given-names>C. M.</given-names></name></person-group><article-title>Prelamin A accelerates vascular calcification via activation of the DNA damage response and senescence-associated secretory phenotype in vascular smooth muscle cells</article-title><source><italic toggle="yes">Circulation Research</italic></source><year>2013</year><volume>112</volume><issue>10</issue><fpage>e99</fpage><lpage>109</lpage><pub-id pub-id-type="doi">10.1161/circresaha.111.300543</pub-id><pub-id pub-id-type="other">2-s2.0-84879808450</pub-id><pub-id pub-id-type="pmid">23564641</pub-id></element-citation></ref><ref id="B67"><label>67</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zwerger</surname><given-names>M.</given-names></name><name><surname>Jaalouk</surname><given-names>D. E.</given-names></name><name><surname>Lombardi</surname><given-names>M. L.</given-names></name><etal/></person-group><article-title>Myopathic lamin mutations impair nuclear stability in cells and tissue and disrupt nucleo-cytoskeletal coupling</article-title><source><italic toggle="yes">Human Molecular Genetics</italic></source><year>2013</year><volume>22</volume><issue>12</issue><fpage>2335</fpage><lpage>2349</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddt079</pub-id><pub-id pub-id-type="other">2-s2.0-84878520431</pub-id><pub-id pub-id-type="pmid">23427149</pub-id></element-citation></ref><ref id="B68"><label>68</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Busch</surname><given-names>A.</given-names></name><name><surname>Kiel</surname><given-names>T.</given-names></name><name><surname>Heupel</surname><given-names>W. M.</given-names></name><name><surname>Wehnert</surname><given-names>M.</given-names></name><name><surname>Hubner</surname><given-names>S.</given-names></name></person-group><article-title>Nuclear protein import is reduced in cells expressing nuclear envelopathy-causing lamin A mutants</article-title><source><italic toggle="yes">Experimental Cell Research</italic></source><year>2009</year><volume>315</volume><issue>14</issue><fpage>2373</fpage><lpage>2385</lpage><pub-id pub-id-type="doi">10.1016/j.yexcr.2009.05.003</pub-id><pub-id pub-id-type="other">2-s2.0-67649185219</pub-id><pub-id pub-id-type="pmid">19442658</pub-id></element-citation></ref><ref id="B69"><label>69</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shumaker</surname><given-names>D. K.</given-names></name><name><surname>Dechat</surname><given-names>T.</given-names></name><name><surname>Kohlmaier</surname><given-names>A.</given-names></name><etal/></person-group><article-title>Mutant nuclear lamin A leads to progressive alterations of epigenetic control in premature aging</article-title><source><italic toggle="yes">Proceedings of the National Academy of Sciences of U S A.</italic></source><year>2006</year><volume>103</volume><issue>23</issue><fpage>8703</fpage><lpage>8708</lpage><pub-id pub-id-type="doi">10.1073/pnas.0602569103</pub-id><pub-id pub-id-type="other">2-s2.0-33745016642</pub-id><pub-id pub-id-type="pmid">16738054</pub-id></element-citation></ref><ref id="B70"><label>70</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maraldi</surname><given-names>N. M.</given-names></name><name><surname>Capanni</surname><given-names>C.</given-names></name><name><surname>Cenni</surname><given-names>V.</given-names></name><name><surname>Fini</surname><given-names>M.</given-names></name><name><surname>Lattanzi</surname><given-names>G.</given-names></name></person-group><article-title>Laminopathies and lamin-associated signaling pathways</article-title><source><italic toggle="yes">Journal of Cellular Biochemistry</italic></source><year>2011</year><volume>112</volume><issue>4</issue><fpage>979</fpage><lpage>992</lpage><pub-id pub-id-type="doi">10.1002/jcb.22992</pub-id><pub-id pub-id-type="other">2-s2.0-79952555799</pub-id><pub-id pub-id-type="pmid">21400569</pub-id></element-citation></ref><ref id="B71"><label>71</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Osmanagic-Myers</surname><given-names>S.</given-names></name><name><surname>Dechat</surname><given-names>T.</given-names></name><name><surname>Foisner</surname><given-names>R.</given-names></name></person-group><article-title>Lamins at the crossroads of mechanosignaling</article-title><source><italic toggle="yes">Genes and Development</italic></source><year>2015</year><volume>29</volume><issue>3</issue><fpage>225</fpage><lpage>237</lpage><pub-id pub-id-type="doi">10.1101/gad.255968.114</pub-id><pub-id pub-id-type="other">2-s2.0-84922154914</pub-id><pub-id pub-id-type="pmid">25644599</pub-id></element-citation></ref><ref id="B72"><label>72</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tapley</surname><given-names>E. C.</given-names></name><name><surname>Starr</surname><given-names>D. A.</given-names></name></person-group><article-title>Connecting the nucleus to the cytoskeleton by SUN-KASH bridges across the nuclear envelope</article-title><source><italic toggle="yes">Current Opinion in Cell Biology</italic></source><year>2013</year><volume>25</volume><issue>1</issue><fpage>57</fpage><lpage>62</lpage><pub-id pub-id-type="doi">10.1016/j.ceb.2012.10.014</pub-id><pub-id pub-id-type="other">2-s2.0-84873701716</pub-id><pub-id pub-id-type="pmid">23149102</pub-id></element-citation></ref><ref id="B73"><label>73</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mejat</surname><given-names>A.</given-names></name><name><surname>Misteli</surname><given-names>T.</given-names></name></person-group><article-title>LINC complexes in health and disease</article-title><source><italic toggle="yes">Nucleus</italic></source><year>2010</year><volume>1</volume><issue>1</issue><fpage>40</fpage><lpage>52</lpage><pub-id pub-id-type="doi">10.4161/nucl.1.1.10530</pub-id><pub-id pub-id-type="other">2-s2.0-77957678443</pub-id><pub-id pub-id-type="pmid">21327104</pub-id></element-citation></ref><ref id="B74"><label>74</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>L.</given-names></name><name><surname>Munck</surname><given-names>M.</given-names></name><name><surname>Swaminathan</surname><given-names>K.</given-names></name><name><surname>Kapinos</surname><given-names>L. E.</given-names></name><name><surname>Noegel</surname><given-names>A. A.</given-names></name><name><surname>Neumann</surname><given-names>S.</given-names></name></person-group><article-title>Mutations in LMNA modulate the lamin A--nesprin-2 interaction and cause LINC complex alterations</article-title><source><italic toggle="yes">PLoS One</italic></source><year>2013</year><volume>8</volume><issue>8, article e71850</issue><pub-id pub-id-type="doi">10.1371/journal.pone.0071850</pub-id><pub-id pub-id-type="other">2-s2.0-84882573661</pub-id><pub-id pub-id-type="pmid">23977161</pub-id></element-citation></ref><ref id="B75"><label>75</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haque</surname><given-names>F.</given-names></name><name><surname>Mazzeo</surname><given-names>D.</given-names></name><name><surname>Patel</surname><given-names>J. T.</given-names></name><etal/></person-group><article-title>Mammalian SUN protein interaction networks at the inner nuclear membrane and their role in laminopathy disease processes</article-title><source><italic toggle="yes">Journal of Biological Chemistry</italic></source><year>2010</year><volume>285</volume><issue>5</issue><fpage>3487</fpage><lpage>3498</lpage><pub-id pub-id-type="doi">10.1074/jbc.M109.071910</pub-id><pub-id pub-id-type="other">2-s2.0-77449109551</pub-id><pub-id pub-id-type="pmid">19933576</pub-id></element-citation></ref><ref id="B76"><label>76</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stewart-Hutchinson</surname><given-names>P. J.</given-names></name><name><surname>Hale</surname><given-names>C. M.</given-names></name><name><surname>Wirtz</surname><given-names>D.</given-names></name><name><surname>Hodzic</surname><given-names>D.</given-names></name></person-group><article-title>Structural requirements for the assembly of LINC complexes and their function in cellular mechanical stiffness</article-title><source><italic toggle="yes">Experimental Cell Research</italic></source><year>2008</year><volume>314</volume><issue>8</issue><fpage>1892</fpage><lpage>1905</lpage><pub-id pub-id-type="doi">10.1016/j.yexcr.2008.02.022</pub-id><pub-id pub-id-type="other">2-s2.0-42649137624</pub-id><pub-id pub-id-type="pmid">18396275</pub-id></element-citation></ref><ref id="B77"><label>77</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meinke</surname><given-names>P.</given-names></name><name><surname>Mattioli</surname><given-names>E.</given-names></name><name><surname>Haque</surname><given-names>F.</given-names></name><etal/></person-group><article-title>Muscular dystrophy-associated SUN1 and SUN2 variants disrupt nuclear-cytoskeletal connections and myonuclear organization</article-title><source><italic toggle="yes">PLOS Genetics</italic></source><year>2014</year><volume>10</volume><issue>9, article e1004605</issue><pub-id pub-id-type="doi">10.1371/journal.pgen.1004605</pub-id><pub-id pub-id-type="other">2-s2.0-84907572500</pub-id><pub-id pub-id-type="pmid">25210889</pub-id></element-citation></ref><ref id="B78"><label>78</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>C.</given-names></name><name><surname>Li</surname><given-names>C.</given-names></name><name><surname>Zhou</surname><given-names>B.</given-names></name><etal/></person-group><article-title>Novel nesprin-1 mutations associated with dilated cardiomyopathy cause nuclear envelope disruption and defects in myogenesis</article-title><source><italic toggle="yes">Human Molecular Genetics</italic></source><year>2017</year><volume>26</volume><issue>12</issue><fpage>2258</fpage><lpage>2276</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddx116</pub-id><pub-id pub-id-type="other">2-s2.0-85030993220</pub-id><pub-id pub-id-type="pmid">28398466</pub-id></element-citation></ref><ref id="B79"><label>79</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>C.</given-names></name><name><surname>Rao</surname><given-names>L.</given-names></name><name><surname>Shanahan</surname><given-names>C. M.</given-names></name><name><surname>Zhang</surname><given-names>Q.</given-names></name></person-group><article-title>Nesprin-1/2: roles in nuclear envelope organisation, myogenesis and muscle disease</article-title><source><italic toggle="yes">Biochemical Society Transactions</italic></source><year>2018</year><volume>46</volume><issue>2</issue><fpage>311</fpage><lpage>320</lpage><pub-id pub-id-type="doi">10.1042/bst20170149</pub-id><pub-id pub-id-type="other">2-s2.0-85046886176</pub-id><pub-id pub-id-type="pmid">29487227</pub-id></element-citation></ref><ref id="B80"><label>80</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chiarini</surname><given-names>F.</given-names></name><name><surname>Evangelisti</surname><given-names>C.</given-names></name><name><surname>Cenni</surname><given-names>V.</given-names></name><etal/></person-group><article-title>The cutting edge: the role of mTOR signaling in laminopathies</article-title><source><italic toggle="yes">International Journal of Molecular Sciences</italic></source><year>2019</year><volume>20</volume><issue>4</issue><fpage>p. 847</fpage><pub-id pub-id-type="doi">10.3390/ijms20040847</pub-id><pub-id pub-id-type="other">2-s2.0-85061873740</pub-id><pub-id pub-id-type="pmid">30781376</pub-id></element-citation></ref><ref id="B81"><label>81</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boriani</surname><given-names>G.</given-names></name><name><surname>Biagini</surname><given-names>E.</given-names></name><name><surname>Ziacchi</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Cardiolaminopathies from bench to bedside: challenges in clinical decision-making with focus on arrhythmia-related outcomes</article-title><source><italic toggle="yes">Nucleus</italic></source><year>2018</year><volume>9</volume><issue>1</issue><fpage>442</fpage><lpage>459</lpage><pub-id pub-id-type="doi">10.1080/19491034.2018.1506680</pub-id><pub-id pub-id-type="other">2-s2.0-85055198813</pub-id><pub-id pub-id-type="pmid">30130999</pub-id></element-citation></ref><ref id="B82"><label>82</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bernasconi</surname><given-names>P.</given-names></name><name><surname>Carboni</surname><given-names>N.</given-names></name><name><surname>Ricci</surname><given-names>G.</given-names></name><etal/></person-group><article-title>Elevated TGF <italic>&#x003b2;</italic>2 serum levels in Emery-Dreifuss muscular dystrophy: implications for myocyte and tenocyte differentiation and fibrogenic processes</article-title><source><italic toggle="yes">Nucleus</italic></source><year>2018</year><volume>9</volume><issue>1</issue><fpage>337</fpage><lpage>349</lpage><pub-id pub-id-type="doi">10.1080/19491034.2018.1467722</pub-id><pub-id pub-id-type="pmid">29693488</pub-id></element-citation></ref><ref id="B83"><label>83</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lombardi</surname><given-names>F.</given-names></name><name><surname>Gullotta</surname><given-names>F.</given-names></name><name><surname>Columbaro</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Compound heterozygosity for mutations in LMNA in a patient with a myopathic and lipodystrophic mandibuloacral dysplasia type A phenotype</article-title><source><italic toggle="yes">The Journal of Clinical Endocrinology &#x00026; Metabolism</italic></source><year>2007</year><volume>92</volume><issue>11</issue><fpage>4467</fpage><lpage>4471</lpage><pub-id pub-id-type="doi">10.1210/jc.2007-0116</pub-id><pub-id pub-id-type="other">2-s2.0-35949003166</pub-id><pub-id pub-id-type="pmid">17848409</pub-id></element-citation></ref><ref id="B84"><label>84</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maggi</surname><given-names>L.</given-names></name><name><surname>Carboni</surname><given-names>N.</given-names></name><name><surname>Bernasconi</surname><given-names>P.</given-names></name></person-group><article-title>Skeletal muscle laminopathies: a review of clinical and molecular features</article-title><source><italic toggle="yes">Cells</italic></source><year>2016</year><volume>5</volume><issue>3</issue><fpage>p. 33</fpage><pub-id pub-id-type="doi">10.3390/cells5030033</pub-id><pub-id pub-id-type="pmid">27529282</pub-id></element-citation></ref><ref id="B85"><label>85</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bera</surname><given-names>M.</given-names></name><name><surname>Kotamarthi</surname><given-names>H. C.</given-names></name><name><surname>Dutta</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Characterization of unfolding mechanism of human lamin A Ig fold by single-molecule force spectroscopy-implications in EDMD</article-title><source><italic toggle="yes">Biochemistry</italic></source><year>2014</year><volume>53</volume><issue>46</issue><fpage>7247</fpage><lpage>7258</lpage><pub-id pub-id-type="doi">10.1021/bi500726f</pub-id><pub-id pub-id-type="other">2-s2.0-84913588958</pub-id><pub-id pub-id-type="pmid">25343322</pub-id></element-citation></ref><ref id="B86"><label>86</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buxboim</surname><given-names>A.</given-names></name><name><surname>Swift</surname><given-names>J.</given-names></name><name><surname>Irianto</surname><given-names>J.</given-names></name><etal/></person-group><article-title>Matrix elasticity regulates lamin-A,C phosphorylation and turnover with feedback to actomyosin</article-title><source><italic toggle="yes">Current Biology</italic></source><year>2014</year><volume>24</volume><issue>16</issue><fpage>1909</fpage><lpage>1917</lpage><pub-id pub-id-type="doi">10.1016/j.cub.2014.07.001</pub-id><pub-id pub-id-type="other">2-s2.0-84906318896</pub-id><pub-id pub-id-type="pmid">25127216</pub-id></element-citation></ref><ref id="B87"><label>87</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Torvaldson</surname><given-names>E.</given-names></name><name><surname>Kochin</surname><given-names>V.</given-names></name><name><surname>Eriksson</surname><given-names>J. E.</given-names></name></person-group><article-title>Phosphorylation of lamins determine their structural properties and signaling functions</article-title><source><italic toggle="yes">Nucleus</italic></source><year>2015</year><volume>6</volume><issue>3</issue><fpage>166</fpage><lpage>171</lpage><pub-id pub-id-type="doi">10.1080/19491034.2015.1017167</pub-id><pub-id pub-id-type="other">2-s2.0-84945182149</pub-id><pub-id pub-id-type="pmid">25793944</pub-id></element-citation></ref><ref id="B88"><label>88</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kochin</surname><given-names>V.</given-names></name><name><surname>Shimi</surname><given-names>T.</given-names></name><name><surname>Torvaldson</surname><given-names>E.</given-names></name><etal/></person-group><article-title>Interphase phosphorylation of lamin A</article-title><source><italic toggle="yes">Journal of Cell Science</italic></source><year>2014</year><volume>127</volume><issue>12</issue><fpage>2683</fpage><lpage>2696</lpage><pub-id pub-id-type="doi">10.1242/jcs.141820</pub-id><pub-id pub-id-type="other">2-s2.0-84902438413</pub-id><pub-id pub-id-type="pmid">24741066</pub-id></element-citation></ref><ref id="B89"><label>89</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cenni</surname><given-names>V.</given-names></name><name><surname>Sabatelli</surname><given-names>P.</given-names></name><name><surname>Mattioli</surname><given-names>E.</given-names></name><etal/></person-group><article-title>Lamin A N-terminal phosphorylation is associated with myoblast activation: impairment in Emery-Dreifuss muscular dystrophy</article-title><source><italic toggle="yes">Journal of Medical Genetics</italic></source><year>2005</year><volume>42</volume><issue>3</issue><fpage>214</fpage><lpage>220</lpage><pub-id pub-id-type="doi">10.1136/jmg.2004.026112</pub-id><pub-id pub-id-type="other">2-s2.0-20144368040</pub-id><pub-id pub-id-type="pmid">15744034</pub-id></element-citation></ref><ref id="B90"><label>90</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cenni</surname><given-names>V.</given-names></name><name><surname>Bertacchini</surname><given-names>J.</given-names></name><name><surname>Beretti</surname><given-names>F.</given-names></name><etal/></person-group><article-title>Lamin A Ser404 is a nuclear target of Akt phosphorylation in C2C12 cells</article-title><source><italic toggle="yes">Journal of Proteome Research</italic></source><year>2008</year><volume>7</volume><issue>11</issue><fpage>4727</fpage><lpage>4735</lpage><pub-id pub-id-type="doi">10.1021/pr800262g</pub-id><pub-id pub-id-type="other">2-s2.0-58149389535</pub-id><pub-id pub-id-type="pmid">18808171</pub-id></element-citation></ref><ref id="B91"><label>91</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bertacchini</surname><given-names>J.</given-names></name><name><surname>Beretti</surname><given-names>F.</given-names></name><name><surname>Cenni</surname><given-names>V.</given-names></name><etal/></person-group><article-title>The protein kinase Akt/PKB regulates both prelamin A degradation and Lmna gene expression</article-title><source><italic toggle="yes">The FASEB Journal</italic></source><year>2013</year><volume>27</volume><issue>6</issue><fpage>2145</fpage><lpage>2155</lpage><pub-id pub-id-type="doi">10.1096/fj.12-218214</pub-id><pub-id pub-id-type="other">2-s2.0-84878760740</pub-id><pub-id pub-id-type="pmid">23430973</pub-id></element-citation></ref><ref id="B92"><label>92</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sabatelli</surname><given-names>P.</given-names></name><name><surname>Bonaldo</surname><given-names>P.</given-names></name><name><surname>Lattanzi</surname><given-names>G.</given-names></name><etal/></person-group><article-title>Collagen VI deficiency affects the organization of fibronectin in the extracellular matrix of cultured fibroblasts</article-title><source><italic toggle="yes">Matrix Biology</italic></source><year>2001</year><volume>20</volume><issue>7</issue><fpage>475</fpage><lpage>486</lpage><pub-id pub-id-type="doi">10.1016/S0945-053X(01)00160-3</pub-id><pub-id pub-id-type="other">2-s2.0-0034751165</pub-id><pub-id pub-id-type="pmid">11691587</pub-id></element-citation></ref><ref id="B93"><label>93</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mattout</surname><given-names>A.</given-names></name><name><surname>Pike</surname><given-names>B.&#x02009;. L.</given-names></name><name><surname>Towbin</surname><given-names>B.&#x02009;. D.</given-names></name><etal/></person-group><article-title>An EDMD mutation in C. elegans lamin blocks muscle-specific gene relocation and compromises muscle integrity</article-title><source><italic toggle="yes">Current Biology</italic></source><year>2011</year><volume>21</volume><issue>19</issue><fpage>1603</fpage><lpage>1614</lpage><pub-id pub-id-type="doi">10.1016/j.cub.2011.08.030</pub-id><pub-id pub-id-type="other">2-s2.0-80054000315</pub-id><pub-id pub-id-type="pmid">21962710</pub-id></element-citation></ref><ref id="B94"><label>94</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perovanovic</surname><given-names>J.</given-names></name><name><surname>Dell&#x02019;Orso</surname><given-names>S.</given-names></name><name><surname>Gnochi</surname><given-names>V. F.</given-names></name><etal/></person-group><article-title>Laminopathies disrupt epigenomic developmental programs and cell fate</article-title><source><italic toggle="yes">Science Translational Medicine</italic></source><year>2016</year><volume>8</volume><issue>335</issue><fpage>p. 335ra58</fpage><pub-id pub-id-type="doi">10.1126/scitranslmed.aad4991</pub-id><pub-id pub-id-type="other">2-s2.0-84964452709</pub-id><pub-id pub-id-type="pmid">27099177</pub-id></element-citation></ref><ref id="B95"><label>95</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brull</surname><given-names>A.</given-names></name><name><surname>Morales Rodriguez</surname><given-names>B.</given-names></name><name><surname>Bonne</surname><given-names>G.</given-names></name><name><surname>Muchir</surname><given-names>A.</given-names></name><name><surname>Bertrand</surname><given-names>A. T.</given-names></name></person-group><article-title>The pathogenesis and therapies of striated muscle laminopathies</article-title><source><italic toggle="yes">Frontiers in Physiology</italic></source><year>2018</year><volume>9, article 1533</volume><pub-id pub-id-type="doi">10.3389/fphys.2018.01533</pub-id><pub-id pub-id-type="other">2-s2.0-85056095380</pub-id></element-citation></ref><ref id="B96"><label>96</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Worman</surname><given-names>H. J.</given-names></name></person-group><article-title>Cell signaling abnormalities in cardiomyopathy caused by lamin A/C gene mutations</article-title><source><italic toggle="yes">Biochemical Society Transactions</italic></source><year>2018</year><volume>46</volume><issue>1</issue><fpage>37</fpage><lpage>42</lpage><pub-id pub-id-type="doi">10.1042/bst20170236</pub-id><pub-id pub-id-type="other">2-s2.0-85045568901</pub-id><pub-id pub-id-type="pmid">29196611</pub-id></element-citation></ref><ref id="B97"><label>97</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chatzifrangkeskou</surname><given-names>M.</given-names></name><name><surname>Le Dour</surname><given-names>C.</given-names></name><name><surname>Wu</surname><given-names>W.</given-names></name><etal/></person-group><article-title>ERK1/2 directly acts on CTGF/CCN2 expression to mediate myocardial fibrosis in cardiomyopathy caused by mutations in the lamin A/C gene</article-title><source><italic toggle="yes">Human Molecular Genetics</italic></source><year>2016</year><volume>25</volume><issue>11</issue><fpage>2220</fpage><lpage>2233</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddw090</pub-id><pub-id pub-id-type="other">2-s2.0-84998655211</pub-id><pub-id pub-id-type="pmid">27131347</pub-id></element-citation></ref><ref id="B98"><label>98</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Angori</surname><given-names>S.</given-names></name><name><surname>Capanni</surname><given-names>C.</given-names></name><name><surname>Faulkner</surname><given-names>G.</given-names></name><etal/></person-group><article-title>Emery-Dreifuss muscular dystrophy-associated mutant forms of lamin A recruit the stress responsive protein Ankrd2 into the nucleus, affecting the cellular response to oxidative stress</article-title><source><italic toggle="yes">Cellular Physiology and Biochemistry</italic></source><year>2017</year><volume>42</volume><issue>1</issue><fpage>169</fpage><lpage>184</lpage><pub-id pub-id-type="doi">10.1159/000477309</pub-id><pub-id pub-id-type="other">2-s2.0-85020204515</pub-id><pub-id pub-id-type="pmid">28531892</pub-id></element-citation></ref><ref id="B99"><label>99</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mattioli</surname><given-names>E.</given-names></name><name><surname>Andrenacci</surname><given-names>D.</given-names></name><name><surname>Mai</surname><given-names>A.</given-names></name><etal/></person-group><article-title>Statins and histone deacetylase inhibitors affect lamin A/C - histone deacetylase 2 interaction in human cells</article-title><source><italic toggle="yes">Frontiers in Cell and Developmental Biology</italic></source><year>2019</year><volume>7</volume><fpage>p. 6</fpage><pub-id pub-id-type="doi">10.3389/fcell.2019.00006</pub-id></element-citation></ref><ref id="B100"><label>100</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mittelbronn</surname><given-names>M.</given-names></name><name><surname>Hanisch</surname><given-names>F.</given-names></name><name><surname>Gleichmann</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Myofiber degeneration in autosomal dominant Emery&#x02013;Dreifuss muscular dystrophy (AD-EDMD) (LGMD1B)</article-title><source><italic toggle="yes">Brain Pathology</italic></source><year>2006</year><volume>16</volume><issue>4</issue><fpage>266</fpage><lpage>272</lpage><pub-id pub-id-type="doi">10.1111/j.1750-3639.2006.00028.x</pub-id><pub-id pub-id-type="other">2-s2.0-33751169102</pub-id><pub-id pub-id-type="pmid">17107595</pub-id></element-citation></ref><ref id="B101"><label>101</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arimura</surname><given-names>T.</given-names></name><name><surname>Helbling-Leclerc</surname><given-names>A.</given-names></name><name><surname>Massart</surname><given-names>C.</given-names></name><etal/></person-group><article-title>Mouse model carrying H222P- Lmna mutation develops muscular dystrophy and dilated cardiomyopathy similar to human striated muscle laminopathies</article-title><source><italic toggle="yes">Human Molecular Genetics</italic></source><year>2005</year><volume>14</volume><issue>1</issue><fpage>155</fpage><lpage>169</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddi017</pub-id><pub-id pub-id-type="other">2-s2.0-19944426537</pub-id><pub-id pub-id-type="pmid">15548545</pub-id></element-citation></ref><ref id="B102"><label>102</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ruggiero</surname><given-names>L.</given-names></name><name><surname>Fiorillo</surname><given-names>C.</given-names></name><name><surname>Tessa</surname><given-names>A.</given-names></name><etal/></person-group><article-title>Muscle fiber type disproportion (FTD) in a family with mutations in the LMNA gene</article-title><source><italic toggle="yes">Muscle &#x00026; Nerve</italic></source><year>2015</year><volume>51</volume><issue>4</issue><fpage>604</fpage><lpage>608</lpage><pub-id pub-id-type="doi">10.1002/mus.24467</pub-id><pub-id pub-id-type="other">2-s2.0-84925460051</pub-id><pub-id pub-id-type="pmid">25256213</pub-id></element-citation></ref><ref id="B103"><label>103</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lallemand-Breitenbach</surname><given-names>V.</given-names></name><name><surname>de Th&#x000e9;</surname><given-names>H.</given-names></name></person-group><article-title>PML nuclear bodies: from architecture to function</article-title><source><italic toggle="yes">Current Opinion in Cell Biology</italic></source><year>2018</year><volume>52</volume><fpage>154</fpage><lpage>161</lpage><pub-id pub-id-type="doi">10.1016/j.ceb.2018.03.011</pub-id><pub-id pub-id-type="other">2-s2.0-85046350295</pub-id><pub-id pub-id-type="pmid">29723661</pub-id></element-citation></ref><ref id="B104"><label>104</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guan</surname><given-names>D.</given-names></name><name><surname>Kao</surname><given-names>H.-Y.</given-names></name></person-group><article-title>The function, regulation and therapeutic implications of the tumor suppressor protein,PML</article-title><source><italic toggle="yes">Cell &#x00026; Bioscience</italic></source><year>2015</year><volume>5</volume><issue>1</issue><fpage>p. 60</fpage><pub-id pub-id-type="doi">10.1186/s13578-015-0051-9</pub-id><pub-id pub-id-type="other">2-s2.0-84946403808</pub-id></element-citation></ref><ref id="B105"><label>105</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Niwa-Kawakita</surname><given-names>M.</given-names></name><name><surname>Ferhi</surname><given-names>O.</given-names></name><name><surname>Soilihi</surname><given-names>H.</given-names></name><name><surname>Le Bras</surname><given-names>M.</given-names></name><name><surname>Lallemand-Breitenbach</surname><given-names>V.</given-names></name><name><surname>de Th&#x000e9;</surname><given-names>H.</given-names></name></person-group><article-title>PML is a ROS sensor activating p53 upon oxidative stress</article-title><source><italic toggle="yes">The Journal of Experimental Medicine</italic></source><year>2017</year><volume>214</volume><issue>11</issue><fpage>3197</fpage><lpage>3206</lpage><pub-id pub-id-type="doi">10.1084/jem.20160301</pub-id><pub-id pub-id-type="other">2-s2.0-85033371445</pub-id><pub-id pub-id-type="pmid">28931625</pub-id></element-citation></ref><ref id="B106"><label>106</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Warren</surname><given-names>D. T.</given-names></name><name><surname>Tajsic</surname><given-names>T.</given-names></name><name><surname>Porter</surname><given-names>L. J.</given-names></name><etal/></person-group><article-title>Nesprin-2-dependent ERK1/2 compartmentalisation regulates the DNA damage response in vascular smooth muscle cell ageing</article-title><source><italic toggle="yes">Cell Death &#x00026; Differentiation</italic></source><year>2015</year><volume>22</volume><issue>9</issue><fpage>1540</fpage><lpage>1550</lpage><pub-id pub-id-type="doi">10.1038/cdd.2015.12</pub-id><pub-id pub-id-type="other">2-s2.0-84938966173</pub-id><pub-id pub-id-type="pmid">25744025</pub-id></element-citation></ref><ref id="B107"><label>107</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harhouri</surname><given-names>K.</given-names></name><name><surname>Navarro</surname><given-names>C.</given-names></name><name><surname>Depetris</surname><given-names>D.</given-names></name><etal/></person-group><article-title>MG132-induced progerin clearance is mediated by autophagy activation and splicing regulation</article-title><source><italic toggle="yes">EMBO Molecular Medicine</italic></source><year>2017</year><volume>9</volume><issue>9</issue><fpage>1294</fpage><lpage>1313</lpage><pub-id pub-id-type="doi">10.15252/emmm.201607315</pub-id><pub-id pub-id-type="other">2-s2.0-85021773460</pub-id><pub-id pub-id-type="pmid">28674081</pub-id></element-citation></ref><ref id="B108"><label>108</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Capanni</surname><given-names>C.</given-names></name><name><surname>Mattioli</surname><given-names>E.</given-names></name><name><surname>Columbaro</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Altered pre-lamin A processing is a common mechanism leading to lipodystrophy</article-title><source><italic toggle="yes">Human Molecular Genetics</italic></source><year>2005</year><volume>14</volume><issue>11</issue><fpage>1489</fpage><lpage>1502</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddi158</pub-id><pub-id pub-id-type="other">2-s2.0-20444449733</pub-id><pub-id pub-id-type="pmid">15843404</pub-id></element-citation></ref><ref id="B109"><label>109</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ivorra</surname><given-names>C.</given-names></name><name><surname>Kubicek</surname><given-names>M.</given-names></name><name><surname>Gonzalez</surname><given-names>J. M.</given-names></name><etal/></person-group><article-title>A mechanism of AP-1 suppression through interaction of c-Fos with lamin A/C</article-title><source><italic toggle="yes">Genes &#x00026; Development</italic></source><year>2006</year><volume>20</volume><issue>3</issue><fpage>307</fpage><lpage>320</lpage><pub-id pub-id-type="doi">10.1101/gad.349506</pub-id><pub-id pub-id-type="other">2-s2.0-32044457898</pub-id><pub-id pub-id-type="pmid">16452503</pub-id></element-citation></ref><ref id="B110"><label>110</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tilgner</surname><given-names>K.</given-names></name><name><surname>Wojciechowicz</surname><given-names>K.</given-names></name><name><surname>Jahoda</surname><given-names>C.</given-names></name><name><surname>Hutchison</surname><given-names>C.</given-names></name><name><surname>Markiewicz</surname><given-names>E.</given-names></name></person-group><article-title>Dynamic complexes of A-type lamins and emerin influence adipogenic capacity of the cell via nucleocytoplasmic distribution of beta-catenin</article-title><source><italic toggle="yes">Journal of Cell Science</italic></source><year>2009</year><volume>122</volume><issue>3</issue><fpage>401</fpage><lpage>413</lpage><pub-id pub-id-type="doi">10.1242/jcs.026179</pub-id><pub-id pub-id-type="other">2-s2.0-65249097788</pub-id><pub-id pub-id-type="pmid">19126678</pub-id></element-citation></ref><ref id="B111"><label>111</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Capanni</surname><given-names>C.</given-names></name><name><surname>Cenni</surname><given-names>V.</given-names></name><name><surname>Haraguchi</surname><given-names>T.</given-names></name><etal/></person-group><article-title>Lamin A precursor induces barrier-to-autointegration factor nuclear localization</article-title><source><italic toggle="yes">Cell Cycle</italic></source><year>2010</year><volume>9</volume><issue>13</issue><fpage>2600</fpage><lpage>2610</lpage><pub-id pub-id-type="doi">10.4161/cc.9.13.12080</pub-id><pub-id pub-id-type="other">2-s2.0-77955438588</pub-id><pub-id pub-id-type="pmid">20581439</pub-id></element-citation></ref><ref id="B112"><label>112</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Capanni</surname><given-names>C.</given-names></name><name><surname>Squarzoni</surname><given-names>S.</given-names></name><name><surname>Cenni</surname><given-names>V.</given-names></name><etal/></person-group><article-title>Familial partial lipodystrophy, mandibuloacral dysplasia and restrictive dermopathy feature barrier-to-autointegration factor (BAF) nuclear redistribution</article-title><source><italic toggle="yes">Cell Cycle</italic></source><year>2012</year><volume>11</volume><issue>19</issue><fpage>3568</fpage><lpage>3577</lpage><pub-id pub-id-type="doi">10.4161/cc.21869</pub-id><pub-id pub-id-type="other">2-s2.0-84867266933</pub-id><pub-id pub-id-type="pmid">22935701</pub-id></element-citation></ref><ref id="B113"><label>113</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ruiz de Eguino</surname><given-names>G.</given-names></name><name><surname>Infante</surname><given-names>A.</given-names></name><name><surname>Schlangen</surname><given-names>K.</given-names></name><etal/></person-group><article-title>Sp1 transcription factor interaction with accumulated prelamin a impairs adipose lineage differentiation in human mesenchymal stem cells: essential role of sp1 in the integrity of lipid vesicles</article-title><source><italic toggle="yes">Stem Cells Translational Medicine</italic></source><year>2012</year><volume>1</volume><issue>4</issue><fpage>309</fpage><lpage>321</lpage><pub-id pub-id-type="doi">10.5966/sctm.2011-0010</pub-id><pub-id pub-id-type="other">2-s2.0-84873730295</pub-id><pub-id pub-id-type="pmid">23197810</pub-id></element-citation></ref><ref id="B114"><label>114</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cenni</surname><given-names>V.</given-names></name><name><surname>Capanni</surname><given-names>C.</given-names></name><name><surname>Mattioli</surname><given-names>E.</given-names></name><etal/></person-group><article-title>Rapamycin treatment of Mandibuloacral dysplasia cells rescues localization of chromatin-associated proteins and cell cycle dynamics</article-title><source><italic toggle="yes">Aging</italic></source><year>2014</year><volume>6</volume><issue>9</issue><fpage>755</fpage><lpage>769</lpage><pub-id pub-id-type="doi">10.18632/aging.100680</pub-id><pub-id pub-id-type="pmid">25324471</pub-id></element-citation></ref><ref id="B115"><label>115</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Infante</surname><given-names>A.</given-names></name><name><surname>Gago</surname><given-names>A.</given-names></name><name><surname>de Eguino</surname><given-names>G. R.</given-names></name><etal/></person-group><article-title>Prelamin A accumulation and stress conditions induce impaired Oct-1 activity and autophagy in prematurely aged human mesenchymal stem cell</article-title><source><italic toggle="yes">Aging</italic></source><year>2014</year><volume>6</volume><issue>4</issue><fpage>264</fpage><lpage>280</lpage><pub-id pub-id-type="doi">10.18632/aging.100651</pub-id><pub-id pub-id-type="other">2-s2.0-84900506715</pub-id><pub-id pub-id-type="pmid">24753226</pub-id></element-citation></ref><ref id="B116"><label>116</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Infante</surname><given-names>A.</given-names></name><name><surname>Rodriguez</surname><given-names>C. I.</given-names></name></person-group><article-title>Pathologically relevant prelamin A interactions with transcription factors</article-title><source><italic toggle="yes">Methods in Enzymology</italic></source><year>2016</year><volume>569</volume><fpage>485</fpage><lpage>501</lpage><pub-id pub-id-type="doi">10.1016/bs.mie.2015.08.032</pub-id><pub-id pub-id-type="other">2-s2.0-84954373335</pub-id><pub-id pub-id-type="pmid">26778572</pub-id></element-citation></ref><ref id="B117"><label>117</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Loi</surname><given-names>M.</given-names></name><name><surname>Cenni</surname><given-names>V.</given-names></name><name><surname>Duchi</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Barrier-to-autointegration factor (BAF) involvement in prelamin A-related chromatin organization changes</article-title><source><italic toggle="yes">Oncotarget</italic></source><year>2016</year><volume>7</volume><issue>13</issue><fpage>15662</fpage><lpage>15677</lpage><pub-id pub-id-type="doi">10.18632/oncotarget.6697</pub-id><pub-id pub-id-type="other">2-s2.0-84971667831</pub-id><pub-id pub-id-type="pmid">26701887</pub-id></element-citation></ref><ref id="B118"><label>118</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boubriak</surname><given-names>I. I.</given-names></name><name><surname>Malhas</surname><given-names>A. N.</given-names></name><name><surname>Drozdz</surname><given-names>M. M.</given-names></name><name><surname>Pytowski</surname><given-names>L.</given-names></name><name><surname>Vaux</surname><given-names>D. J.</given-names></name></person-group><article-title>Stress-induced release of Oct-1 from the nuclear envelope is mediated by JNK phosphorylation of lamin B1</article-title><source><italic toggle="yes">PLoS One</italic></source><year>2017</year><volume>12</volume><issue>5, article e0177990</issue><pub-id pub-id-type="doi">10.1371/journal.pone.0177990</pub-id><pub-id pub-id-type="other">2-s2.0-85019945128</pub-id><pub-id pub-id-type="pmid">28542436</pub-id></element-citation></ref><ref id="B119"><label>119</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dialynas</surname><given-names>G.</given-names></name><name><surname>Shrestha</surname><given-names>O. K.</given-names></name><name><surname>Ponce</surname><given-names>J. M.</given-names></name><etal/></person-group><article-title>Myopathic lamin mutations cause reductive stress and activate the nrf2/keap-1 pathway</article-title><source><italic toggle="yes">Plos Genetics</italic></source><year>2015</year><volume>11</volume><issue>5, article e1005231</issue><pub-id pub-id-type="doi">10.1371/journal.pgen.1005231</pub-id><pub-id pub-id-type="other">2-s2.0-84930811144</pub-id><pub-id pub-id-type="pmid">25996830</pub-id></element-citation></ref><ref id="B120"><label>120</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bertrand</surname><given-names>A. T.</given-names></name><name><surname>Renou</surname><given-names>L.</given-names></name><name><surname>Papadopoulos</surname><given-names>A.</given-names></name><etal/></person-group><article-title>DelK32-lamin A/C has abnormal location and induces incomplete tissue maturation and severe metabolic defects leading to premature death</article-title><source><italic toggle="yes">Human Molecular Genetics</italic></source><year>2012</year><volume>21</volume><issue>5</issue><fpage>1037</fpage><lpage>1048</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddr534</pub-id><pub-id pub-id-type="other">2-s2.0-84856951638</pub-id><pub-id pub-id-type="pmid">22090424</pub-id></element-citation></ref><ref id="B121"><label>121</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sullivan</surname><given-names>T.</given-names></name><name><surname>Escalante-Alcalde</surname><given-names>D.</given-names></name><name><surname>Bhatt</surname><given-names>H.</given-names></name><etal/></person-group><article-title>Loss of A-type lamin expression compromises nuclear envelope integrity leading to muscular dystrophy</article-title><source><italic toggle="yes">Journal of Cell Biology</italic></source><year>1999</year><volume>147</volume><issue>5</issue><fpage>913</fpage><lpage>920</lpage><pub-id pub-id-type="doi">10.1083/jcb.147.5.913</pub-id><pub-id pub-id-type="other">2-s2.0-0033615969</pub-id><pub-id pub-id-type="pmid">10579712</pub-id></element-citation></ref><ref id="B122"><label>122</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kojic</surname><given-names>S.</given-names></name><name><surname>Radojkovic</surname><given-names>D.</given-names></name><name><surname>Faulkner</surname><given-names>G.</given-names></name></person-group><article-title>Muscle ankyrin repeat proteins: their role in striated muscle function in health and disease</article-title><source><italic toggle="yes">Critical Reviews in Clinical Laboratory Sciences</italic></source><year>2011</year><volume>48</volume><issue>5-6</issue><fpage>269</fpage><lpage>294</lpage><pub-id pub-id-type="doi">10.3109/10408363.2011.643857</pub-id><pub-id pub-id-type="other">2-s2.0-84055197774</pub-id><pub-id pub-id-type="pmid">22185618</pub-id></element-citation></ref><ref id="B123"><label>123</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pallavicini</surname><given-names>A.</given-names></name><name><surname>Kojic</surname><given-names>S.</given-names></name><name><surname>Bean</surname><given-names>C.</given-names></name><etal/></person-group><article-title>Characterization of human skeletal muscle Ankrd2</article-title><source><italic toggle="yes">Biochemical and Biophysical Research Communications</italic></source><year>2001</year><volume>285</volume><issue>2</issue><fpage>378</fpage><lpage>386</lpage><pub-id pub-id-type="doi">10.1006/bbrc.2001.5131</pub-id><pub-id pub-id-type="other">2-s2.0-0034816094</pub-id><pub-id pub-id-type="pmid">11444853</pub-id></element-citation></ref><ref id="B124"><label>124</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bean</surname><given-names>C.</given-names></name><name><surname>Salamon</surname><given-names>M.</given-names></name><name><surname>Raffaello</surname><given-names>A.</given-names></name><name><surname>Campanaro</surname><given-names>S.</given-names></name><name><surname>Pallavicini</surname><given-names>A.</given-names></name><name><surname>Lanfranchi</surname><given-names>G.</given-names></name></person-group><article-title>The Ankrd2, Cdkn1c and calcyclin genes are under the control of MyoD during myogenic differentiation</article-title><source><italic toggle="yes">Journal of Molecular Biology</italic></source><year>2005</year><volume>349</volume><issue>2</issue><fpage>349</fpage><lpage>366</lpage><pub-id pub-id-type="doi">10.1016/j.jmb.2005.03.063</pub-id><pub-id pub-id-type="other">2-s2.0-18844417079</pub-id><pub-id pub-id-type="pmid">15890200</pub-id></element-citation></ref><ref id="B125"><label>125</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carson</surname><given-names>J. A.</given-names></name><name><surname>Nettleton</surname><given-names>D.</given-names></name><name><surname>Reecy</surname><given-names>J. M.</given-names></name></person-group><article-title>Differential gene expression in the rat soleus muscle during early work overload-induced hypertrophy</article-title><source><italic toggle="yes">The FASEB Journal</italic></source><year>2002</year><volume>16</volume><issue>2</issue><fpage>207</fpage><lpage>209</lpage><pub-id pub-id-type="doi">10.1096/fj.01-0544fje</pub-id><pub-id pub-id-type="pmid">11744623</pub-id></element-citation></ref><ref id="B126"><label>126</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>Y. W.</given-names></name><name><surname>Nader</surname><given-names>G. A.</given-names></name><name><surname>Baar</surname><given-names>K. R.</given-names></name><name><surname>Fedele</surname><given-names>M. J.</given-names></name><name><surname>Hoffman</surname><given-names>E. P.</given-names></name><name><surname>Esser</surname><given-names>K. A.</given-names></name></person-group><article-title>Response of rat muscle to acute resistance exercise defined by transcriptional and translational profiling</article-title><source><italic toggle="yes">The Journal of Physiology</italic></source><year>2002</year><volume>545</volume><issue>1</issue><fpage>27</fpage><lpage>41</lpage><pub-id pub-id-type="doi">10.1113/jphysiol.2002.021220</pub-id><pub-id pub-id-type="other">2-s2.0-0037112473</pub-id><pub-id pub-id-type="pmid">12433947</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="fig1" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Overview of Ankrd2 isoforms. (a) Schematic presentation of the Ankrd2 domain structure. (b) Alignment of protein sequences of Ankrd2 isoforms. Numbers correspond to amino acids. (c) Entries for five Ankrd2 isoforms reported in NCBI and Ensembl databases. <sup>&#x02217;</sup>NCBI entries were updated in 2018.</p></caption><graphic xlink:href="OMCL2019-7318796.001"/></fig><fig id="fig2" orientation="portrait" position="float"><label>Figure 2</label><caption><p>Interaction network for Ankrd2. Interactors listed in <xref rid="tab1" ref-type="table">Table 1</xref> were loaded into the STRING database: <ext-link ext-link-type="uri" xlink:href="https://string-db.org/">https://string-db.org/</ext-link>. The majority of Ankrd2 interactors, including titin, telethonin, Ankrd1, Ankrd23, ZASP6, and calpain 3, are involved in mechanosignaling. Other Ankrd2 interacting proteins are involved in DNA binding and regulation of transcription and include p53, MECP2, ID3, YB-1, PAX6, PML, and NF-IL3. A-type lamins, including lamin A, its precursor prelamin A, and lamin C, are Ankrd2 interactors and are involved in multiple cellular functions, including modulation of the nuclear stiffness in response to mechanical and oxidative stress and of epigenetic factor activity. Ankrd2 also interacts with protein kinases, as Akt2, and with proteins with PDZ or SH3 domains able to mediate protein-protein interactions (including ZO-1 and <italic>&#x003b2;</italic>1-syntrophin, respectively). Note that the majority of Ankrd2 interactors were identified from in vitro studies or in nonmuscular cellular systems (see text and <xref rid="tab1" ref-type="table">Table 1</xref> for references).</p></caption><graphic xlink:href="OMCL2019-7318796.002"/></fig><fig id="fig3" orientation="portrait" position="float"><label>Figure 3</label><caption><p>Proposed pathogenic mechanisms in which Ankrd2 might be involved. In healthy muscle cells, physiological amounts of ROS or muscle differentiation induce Ankrd2 phosphorylation by Akt2 [<xref rid="B15" ref-type="bibr">15</xref>] and translocation into the nucleus, by binding to A-type lamins (black mesh) [<xref rid="B98" ref-type="bibr">98</xref>]. In the nucleus, Ankrd2 modulates the activation of muscle-specific and stress-responsive genes, by interacting with transcription factors (see text and <xref rid="tab1" ref-type="table">Table 1</xref> for references). In laminopathic muscle cells, mutated A-type lamins (red mesh) even in the absence of external stimuli recruit Ankrd2 into the nucleus. In addition to the already reported consequences, including an anomalous increase of ROS release, myogenic delay, and apoptotic cell death [<xref rid="B98" ref-type="bibr">98</xref>], potential pathogenic mechanisms, through which the altered nuclear localization of Ankrd2 might contribute to the pathogenesis of <italic>LMNA</italic>-related muscular disorders, are proposed.</p></caption><graphic xlink:href="OMCL2019-7318796.003"/></fig><table-wrap id="tab1" orientation="portrait" position="float"><label>Table 1</label><caption><p>Overview of the main structural and functional features of Ankrd2 (extensively reported in [<xref rid="B122" ref-type="bibr">122</xref>]).</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Feature</th><th align="center" rowspan="1" colspan="1">Ref.</th></tr></thead><tbody><tr><td align="left" colspan="2" rowspan="1">
<italic>Structural domains</italic>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Ankyrin repeats</td><td align="center" rowspan="4" colspan="1">[<xref rid="B123" ref-type="bibr">123</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">Coiled coil</td></tr><tr><td align="left" rowspan="1" colspan="1">Protein destabilization motif (PEST)</td></tr><tr><td align="left" rowspan="1" colspan="1">Nuclear localization signal (NLS)</td></tr><tr><td align="left" colspan="2" rowspan="1">
<italic>Posttranslational modifications</italic>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Phosphorylation by Akt2 kinase</td><td align="center" rowspan="1" colspan="1">[<xref rid="B15" ref-type="bibr">15</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">Proteolytic cleavage by <italic>&#x003bc;</italic>-calpain</td><td align="center" rowspan="1" colspan="1">[<xref rid="B9" ref-type="bibr">9</xref>]</td></tr><tr><td align="left" colspan="2" rowspan="1">
<italic>Expression profile</italic>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Skeletal&#x02009;muscle &#x0003e; heart &#x0003e; kidney</td><td align="center" rowspan="1" colspan="1">[<xref rid="B4" ref-type="bibr">4</xref>, <xref rid="B19" ref-type="bibr">19</xref>, <xref rid="B123" ref-type="bibr">123</xref>, <xref rid="B124" ref-type="bibr">124</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">Type I (slow) skeletal muscle fibers</td><td align="center" rowspan="1" colspan="1">[<xref rid="B8" ref-type="bibr">8</xref>, <xref rid="B123" ref-type="bibr">123</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">Localized in nuclei of myoblasts and cytoplasm of myotubes</td><td align="center" rowspan="1" colspan="1">[<xref rid="B123" ref-type="bibr">123</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">Migrate from myofibrils to nucleus after muscle injury</td><td align="center" rowspan="1" colspan="1">[<xref rid="B10" ref-type="bibr">10</xref>]</td></tr><tr><td align="left" colspan="2" rowspan="1">
<italic>Proposed functions</italic>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Stress response in muscle (stretch, denervation, eccentric contractions, fatiguing jumping and other types of exercise, and injury)</td><td align="center" rowspan="1" colspan="1">[<xref rid="B8" ref-type="bibr">8</xref>, <xref rid="B10" ref-type="bibr">10</xref>, <xref rid="B16" ref-type="bibr">16</xref>, <xref rid="B46" ref-type="bibr">46</xref>, <xref rid="B47" ref-type="bibr">47</xref>, <xref rid="B49" ref-type="bibr">49</xref>, <xref rid="B50" ref-type="bibr">50</xref>, <xref rid="B55" ref-type="bibr">55</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">Muscle adaptation</td><td align="center" rowspan="1" colspan="1">[<xref rid="B7" ref-type="bibr">7</xref>, <xref rid="B10" ref-type="bibr">10</xref>, <xref rid="B16" ref-type="bibr">16</xref>, <xref rid="B20" ref-type="bibr">20</xref>, <xref rid="B46" ref-type="bibr">46</xref>, <xref rid="B47" ref-type="bibr">47</xref>, <xref rid="B49" ref-type="bibr">49</xref>, <xref rid="B50" ref-type="bibr">50</xref>, <xref rid="B125" ref-type="bibr">125</xref>, <xref rid="B126" ref-type="bibr">126</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">Transcriptional regulation</td><td align="center" rowspan="1" colspan="1">[<xref rid="B1" ref-type="bibr">1</xref>, <xref rid="B10" ref-type="bibr">10</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">Communication between the sarcoplasm and the nucleus</td><td align="center" rowspan="1" colspan="1">[<xref rid="B1" ref-type="bibr">1</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">Myogenesis and myogenic differentiation</td><td align="center" rowspan="1" colspan="1">[<xref rid="B11" ref-type="bibr">11</xref>, <xref rid="B13" ref-type="bibr">13</xref>, <xref rid="B14" ref-type="bibr">14</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">Inflammatory response</td><td align="center" rowspan="1" colspan="1">[<xref rid="B12" ref-type="bibr">12</xref>]</td></tr><tr><td align="left" colspan="2" rowspan="1">
<italic>Interacting proteins</italic>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Titin</td><td align="center" rowspan="1" colspan="1">[<xref rid="B7" ref-type="bibr">7</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">Telethonin</td><td align="center" rowspan="1" colspan="1">[<xref rid="B1" ref-type="bibr">1</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">ZASP</td><td align="center" rowspan="1" colspan="1">[<xref rid="B30" ref-type="bibr">30</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">Calpain 3</td><td align="center" rowspan="1" colspan="1">[<xref rid="B9" ref-type="bibr">9</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">Akt2</td><td align="center" rowspan="1" colspan="1">[<xref rid="B15" ref-type="bibr">15</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">A-type lamins (lamin A, prelamin A, and lamin C)</td><td align="center" rowspan="1" colspan="1">[<xref rid="B98" ref-type="bibr">98</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">Proteins with PDZ and SH3 domains, including ZO-1 and <italic>&#x003b2;</italic>1-syntrophin</td><td align="center" rowspan="1" colspan="1">[<xref rid="B20" ref-type="bibr">20</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">Transcription factors, including YB1, p53, PML, PAX6, NFIL3, and MECP2</td><td align="center" rowspan="1" colspan="1">[<xref rid="B20" ref-type="bibr">20</xref>]</td></tr><tr><td align="left" colspan="2" rowspan="1">
<italic>Pathways affected by Ankrd2 silencing in human myoblasts</italic>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Intercellular communication</td><td align="center" rowspan="13" colspan="1">[<xref rid="B20" ref-type="bibr">20</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Cytokine-cytokine receptor interaction</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Focal adhesion</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Tight junction</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Gap junction</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Regulation of actin cytoskeleton</td></tr><tr><td align="left" rowspan="1" colspan="1">Signaling involved in intracellular communication</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Calcium</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Insulin</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;MAPK</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;p53</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;TGF-<italic>&#x003b2;</italic></td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Wnt</td></tr></tbody></table></table-wrap></floats-group></article>
